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To date, antibiotics have been widely used in conventional animal medicine, as they are 
non-selective, as well as effective in killing pathogenic bacteria (Conly and Johnston, 2004). 
However, there is mounting concern over the increasing emergence of antibiotic-resistant 
bacteria due to the use of less innovative antibiotics; and moreover, the overuse of antibiotics in 
general (Llor and Bjerrum, 2014). Since antibiotics have been shown to kill-off beneficial 
bacteria in the gut, the development of possible alternatives to antibiotics has therefore come to 
the forefront as a solution to this agricultural-human health related issue. Maternal stress during 
late gestation may impair the development and reactivity of the sow’s offspring which impacts 
disease susceptibility and mortality (Chu et al., 2016). The European-wide ban on antibiotics as 
growth promoters initially has had detrimental effects with reported increased morbidity and 
mortality in pigs, increases in enteric infections leading to increases in clinical diarrhea, and 
reduced weight gains (Hao et al., 2014). The utilization of probiotics as a method of promoting 
healthy gut bacteria may potentially restore the composition of the gut microbiome and may 
result in amelioration or prevention of gut inflammation (Hemarajata and Versalovic, 2012). 
Whether or not these potential alternatives are suitable to replace antibiotics as growth promoters 
or preventatives, or act as a co-product to these dietary supplements, is still unclear. 
Feeding modified gestation diets, specifically the yeast probiotic, Saccharomyces 
cerevisiae boulardii (Scb), to sows throughout pregnancy could improve the immune status and 
stress responsiveness of both the dam and her progeny. The objectives of the sow study were to 
(1) assess the effects of the yeast probiotic treatment, Scb, on the immune status and cortisol 
levels of pregnant sows during late gestation (d 84 – d 112 of gestation); and to (2) assess the 
effects of the yeast probiotic treatment, Scb, on the stress responsiveness of sows at farrowing 
and weaning during the lactation period (d 112 – d 135). The objectives of the piglet study were 
to (1) assess the effects of feeding yeast probiotics, Scb, to sows during late gestation through 
lactation on the immune status of her piglets from birth till weaning (d 0 – d 21 of age); and to 
(2) assess the stress responsiveness of her piglets in response to farrowing and processing 
stressors, as well as the effects on the stress responsiveness of piglets to weaning stress in short- 
and long-term periods (d 21 – d 35 of age).  
A total of eighteen pregnant sows, derived from the Genetiporc maternal line, were used 
in this study. Sows were randomly assigned to either the control treatment (CON-sows) or the 
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probiotic treatment (PRO-sows) starting on d 84 of gestation (baseline for the experiment). Sows 
were hand-fed either two boluses of the CON (placebo) or PRO (probiotic) daily at 0700 h 
starting on d 84 of gestation and ending on day of weaning (d 135). Sows were nose-snared to 
collect blood samples on gestational days 84, 91, 98, 105, and 112, and again on lactation days 
115 (24 hours post-farrowing) and 135 (weaning). A total of eighty-four female piglets, born to 
sows derived of the Genetiporc maternal line were used in the piglet study (n = 84 piglets; 42 
piglets/treatment). Fixed-effects parameters of treatment (control or probiotic-treated sows) and 
day of age for piglets were used for this study. Piglets were not directly fed the probiotic 
treatment during this research; rather, the maternal-fetal interaction was analyzed to assess the 
effects of the treatment given to the sows on the resulting immune status and stress 
responsiveness of the progeny.  
When presented with a challenge, such as farrowing and weaning stress in sows or 
farrowing, processing, and weaning stress in piglets, the yeast probiotic, Scb was shown to have 
a treatment x day interaction (p ≤ 0.05) on stress responsiveness, which included changes in 
immune status as well. The data imply that the increased immune status and stress response of 
the sows and piglets are interrelated in some cases, which can be changed with the inclusion of 
Scb. In general, few treatment x day interactions occurred for any measure assessed during 
gestation or lactation, except for plasma cortisol, natural killer cell cytotoxicity, neutrophil 
chemotaxis C5a and IL-8, Interleukin-12, and the leukocyte differential. Moreover, few 
treatment x day interactions occurred in piglets for any measure assessed during suckling or 
weaning, except for plasma cortisol, total white blood cell count, total neutrophil and lymphocyte 
counts, leukocyte differential, neutrophil phagocytosis, natural killer cell cytotoxicity, 
Interleukin-12, and LPS-induced mitogen proliferation.  
Some aspects of innate immunity implied that the PRO-piglets’ immune system was 
being affected by the Scb probiotic. The immune effects that occurred during the first 24-hours 
of age for the PRO-piglets were most likely due to the treatment that the probiotic-treated sows 
were given during late gestation. In addition, the immune effects that the PRO-piglets 
experienced from d 0 (birth) to d 7 of age were likely due to the PRO-sows’ treatment during 
gestation and lactation. Therefore, it is possible that feeding PRO-sows the yeast probiotic 
supplementation during the periods of gestation and lactation, resulted in positive outcomes of 
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CHAPTER ONE: LITERATURE REVIEW 
 
INTRODUCTION 
To date, antibiotics have been widely used in conventional animal medicine, as they are non-
selective, as well as effective in killing pathogenic bacteria (Conly and Johnston, 2004). 
However, there is mounting concern over the increasing emergence of antibiotic-resistant 
bacteria due to the use of less innovative antibiotics; and moreover, the overuse of antibiotics in 
general (Llor and Bjerrum, 2014). The development of possible alternatives to antibiotics has 
therefore come to the forefront as a solution to this agricultural-human health related issue. The 
current use, and what is perceived by some as the misuse, of antibiotics in the food animal 
production industry is of particular interest to the accompanying literature review of research 
conducted on pig nutrition and management practices. It highlights a relatively new form of feed 
additive category, probiotics, which has the potential to supplement and/or replace antibiotics as 
a growth promotant or for immune enhancement. This review discusses the pros and cons of past 
and current antibiotic uses in animal agriculture, the pros and cons of the development and use of 
probiotics in the food-animal industry, as well as concerns associated with human and swine 
health and the possibility of emerging bacterial resistance.  
The role of probiotics and antibiotics to maintain a healthy and balanced microbiota in swine 
production is of particular interest, including the use of a specific yeast probiotic, Saccharomyces 
cerevisiae boulardii (Scb). Future research of alternatives to the use of antibiotics in animal 
agriculture may include the utilization of prebiotics, synbiotics, and/or phytogenics as well 
(Pandey et al., 2015). The gastrointestinal tract is of vital importance to the overall health and 
well-being of the animal, as it is the primary site of interaction between the host immune system, 
as well as both symbiotic and pathogenic microorganisms (Round and Mazmanian, 2014).With 
this in mind, research implies that direct-fed microbials provided in the diets of food animals 
intended for human consumption should meet four major criteria to be a viable alternative: (1) 
treatment of infectious diseases, (2) control of infectious diseases, (3) prevention of infectious 
diseases, and (4) antimicrobial compounds used for the growth promotion and feed efficiency of 
the food animals (FDA, 2012).  
Probiotics are defined as living microbial adjuncts, which confer a health benefit onto the 
host, such as the prevention and treatment of pathological conditions (Czerucka et al., 2007). 
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Yeasts are a large and heterogeneous group of eukaryotic microorganisms, which are important 
when considering the probiotic properties of yeasts. These probiotics can elicit changes in the 
intestinal microbiota, and improve animal performance via host-specific alterations; however, the 
exact benefits that probiotics provide animals in production systems is unclear (O’Toole and 
Cooney, 2008). Potential mechanisms of Scb probiotics may include inhibition of certain 
bacterial toxins/subsequent pathogenic effects, trophic effects, anti-secretory activity, and 
immune-stimulatory effects on the intestinal mucosa (Stier and Bischoff, 2016).  
There are vital factors that need to be considered when deciding which means of direct-fed 
microbial (antibiotics vs. probiotics in this case) is the most suitable practice to utilize in food 
animals. Cheng et al. (2014) and Cho et al. (2011) noted that reliable and efficient feed additives 
for animal production should result in a balanced gut microbiome that improves digestibility at a 
low cost to the producer, while reducing the impact (i.e., animal health, growth, and feed 
utilization) of unavoidable stressors. Increase in nutrient uptake and digestibility may improve 
animal welfare in terms of enhanced immune function and production efficiency, as well as 
reductions in waste management issues, overall mortality rates, and food borne pathogens (i.e., 
food safety concerns).  
In Denmark, the ban on the use of subtherapeutic antibiotics in the industry was concluded as 
not having a positive effect on their pork industry. The ban resulted in a handful of unintended 
consequences, including: an increase in death and diseased animals; an increase in the use of 
antibiotics to treat sick animals (with the total use only slightly decreased); and while the 
resistance to some antibiotics decreased in animals, resistance to others increased (Hurd, 2011). 
Denmark’s ban of all food animal antibiotics in 2000 showed very little positive impact on either 
human health or a decline in resistance. Consequently, there has been an increase in the use of 
antibiotics in order to treat sick animals (Hurd, 2011). Instead of Denmark’s ban on antibiotics as 
growth promotants (AGPs) reducing the incidence of antibiotic resistance in humans, it was 
found to increase animal suffering, pain, and death (APUA, 2010).  
Challenges associated with reducing the use of antibiotic growth promoters, requiring longer 
withdrawal phases or the outright elimination of their use, could exacerbate nutritional and 
environmental stressors. If probiotics were to become a central part of food animals’ diets, then 
the manner in which these feed additives benefit health and are eventually excreted in the feces 
would need to be documented. Variables such as the timing in which the feeding of probiotics 
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begins (which would have to be started early in the animal’s life to be effective) would affect the 
establishment of a healthy gut population (Yirga, 2015). Thereafter, in order for the probiotic 
supplements to continue to be effective, the continued feeding of this specific diet would need to 
be ensured throughout the production cycle. This is because probiotic species are diverse, and by 
consequence, vary in their modes of action and efficiency (Danisco Animal Nutrition, 2014).  
Within the accompanying thesis, it is essential to analyze multiple immune and endocrine 
variables in order to better understand the responses that animals have to pathogenic challenges, 
as well as the resulting impact on growth. Past research has found that probiotics act largely by 
competing with enteric pathogens, balancing colonic microbiota, influencing the intestinal 
barrier, and modulating the systemic and mucosal immune systems (Hemarajata and Versalovic, 
2012). During the period of lactation, it is necessary for the sow to activate body reserves. This is 
done in order to compensate for reduced feed intake, as well as to meet the nutritional demand 
for milk production. Maternal nutrition, as it relates to fetal growth and development, has the 
potential to influence metabolic, endocrine, and cardiovascular diseases in offspring (Delisle, 
2002). Changes to the nutrition and the endocrine status of the offspring may result in permanent 
changes to structure, physiology, and metabolism of the offspring. Therefore, postnatal 
performance within pork production systems is crucial for solving future potential economic 
difficulties. Delisle (2002) described developmental programming as the long-term effects that 
“stressors” may have on fetal or neonatal development. The programming of organ systems 
during the developmental period can thereby alter offspring function, whether it occurs postnatal 
or later in life. Fetal programming further refers to the process by which an acute or chronic 
stimulus (i.e., in the uterus) establishes a permanent response in the fetus that impacts 
physiological function later in life. Optimal maternal nutrition and the intrauterine environment 
are the keys to ensuring ideal fetal development and a reduced risk of chronic disease in the later 
life of offspring (Lee, 2015). Therefore, maternal nutrition is important for body weight during 
pregnancy, overall health of the animal, fetal growth, and lactation performance.  
 
THE ANTIBIOTIC VS. PROBIOTIC DEBATE 
To date, pork is the most widely consumed and most in-demand meat protein in the world 
(Pork Checkoff, 2017). Since the World Health Organization’s 2014 statement on antibiotic 
resistance, calling the topic a “major global threat” (WHO, 2014) to public health, the desire for 
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the use of antibiotic-free practices in food animal production industries has been emphasized.   
Since the 1940s, antibiotics have been widely used in food animals in the U.S. as a means of 
preventing animals from disease and improving performance efficiency (National Research 
Council (U.S.) Committee, 1980). Antibiotics have been used to prevent, control, and treat 
infectious diseases, but the benefits in the food animals have also resulted in enhanced feed 
efficiency, improved animal growth, and overall improvement in the quality of the animal 
product. Antibiotics inhibit the growth of, or destroy, microorganisms (US National Library of 
Medicine, 2016). By targeting bacteria in the body, antibiotics can cure bacterial infections; 
however, in the case of viral infections, antibiotics are ineffective. A probiotic is a 
microorganism that is introduced into the body for its beneficial qualities, often as a food or 
dietary supplement. Probiotics contain live organisms that either replace, or add to, the beneficial 
microbes already found in the gastrointestinal tract (Jo DiLonardo, 2016). Since probiotics are 
naturally-occurring live microbes intended to improve the gut flora, they are often administered 
as a directly-fed microbial that is added to feed. Moreover, probiotics are noted as having the 
ability to alter the pH (acidity) of the gut in order to allow or prevent the growth of other types of 
bacteria (Prebiotin, 2011).  
Antibiotic therapy may disrupt normal bacterial population of the digestive tract, resulting in 
the colonization of harmful bacteria in the gut (Langdon et al., 2016), which can irritate the gut 
and cause antibiotic associated diarrhea (AAD). Antibiotic associated diarrhea is one of the most 
common side effects associated with the use of antibiotics in swine production. Past studies have 
shown that feeding Scb to pigs in common production environments may improve gut function 
of the weaned pigs and prevent AAD (Kelesidis, 2012). There is speculation that utilizing 
alternatives to antibiotics could be the first and foremost step in slowing the progress of 
antibiotic resistance Cheng et al. (2014). Supplementing production animals’ diets with a feed 
additive other than antibiotics would change the way we use and prescribe these antibiotics. It is 
the expectation that regulation of antibiotics in animal production would limit their use on farms, 
turning instead to healthy bacteria that can fill the gap: probiotics. With an ever-increasing 
demand for pork, coupled with the expanding list of food brands that want to eliminate the use of 
antibiotics in livestock due to welfare concerns, producers and retailers alike must look to the 
future for ways in which to assure disease prevention, growth promotion, and animal well-being, 
while incorporating these new approaches to ensuring a healthy animal gut flora.  
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Different species of probiotics currently in use include various lactic acid bacteria, Bacillus 
species, and yeasts (such as Saccharomyces cerevisiae and Aspergillus oryzae), to name a few. 
Of these species, Bacillus, Enterococcus, and Saccharomyces yeast are noted as the most 
commonly used in the livestock feed industry (Cho et al., 2011). By using probiotics in addition 
to a reduced amount of antibiotics in animal feed, beneficial microbes would be able to 
repopulate the intestinal tract (Danisco Animal Nutrition, 2014). A healthy nutritional status 
would maintain optimal gut health and support absorption of nutrients, all while improving feed 
efficiency. Therefore, it can be argued that effective strains of probiotic products should be 
combined with effective anti-coccidial drugs, which have been effectively used for years as a 
preventative in feed medication.  
Agricultural applications of probiotics include live microbial feed supplements that improve 
the intestinal microbial balance in the animal. Probiotics are often used in poultry, ruminants, 
pigs, and aquaculture, in order to improve animal health and food safety. For example, feeding 
Holstein calves Lactic acid bacteria (LAB) and yeast diets resulted in improved growth rate and 
suppressed incidence of diarrhea (Kawakami et al., 2010). While in pigs, feeding Bacillus 
species as a probiotic reduced both pathogen load and gastrointestinal disease symptoms (Gaggia 
et al., 2010). Probiotics can produce inhibitory compounds including volatile fatty acids and 
hydrogen peroxide which may result in enhanced host resistance to enteric pathogens, via the 
inhibition of harmful bacterial growth (Jin et al., 2000). The use of probiotics in animal health 
has resulted in a plethora of benefits to the host; such as providing animals with additional 
sources of nutrients and digestive enzymes, and stimulating B-vitamin synthesis (LeBlanc et al., 
2011). 
Probiotic feed supplements may improve pathogenic bacteria resistance in livestock, 
including defending the digestive system against harmful microorganisms such as 
enteropathogenic E. coli, Salmonella, Listeria species, and Helicobacter pylori (Conly and 
Johnston, 2004). It has been suggested that improvement in intestinal microbial balance results in 
enhanced efficiency and performance during times of stress and gut acclimation (FAO, 2016). 
With the anticipation that the addition of probiotics to animal feed would minimize the effects of 
common production stressors on animal health and well-being, this then would allow for an 
increase in nutrient uptake while simultaneously reducing waste (Dhama et al., 2008).  
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As reported by Jacela et al. (2010) in a review regarding feed additives for swine, the 
possibility of utilizing prebiotics, synbiotics, and/or phytogenics were also considered as 
alternatives to the use of antibiotics. Prebiotics benefit the gut of the animal as they are “non-
digestible food substances that selectively stimulate the growth of favorable species of bacteria” 
(Gibson and Roberfroid, 1995). Research on the use of prebiotics has produced inconsistent 
results, with differences indicating that both the environment, as well as production practices, 
play a role in the lack of reliability of these feed additives. It has also been proposed that the 
prebiotics were insufficient in their ability to survive and become established within the 
gastrointestinal tract, which could be attributed specifically to the number of viable organisms 
that are found within each dose of prebiotic feed additive. The second alternative feed additive 
suggested from this research was synbiotics (the combination of both prebiotics and probiotics). 
Potential benefits of synbiotics include the improved survival rate and colonization of the 
probiotic microorganisms; however, inconsistent results again hinder this alternative from being 
utilized in the industry. Finally, phytogenic feed additives (e.g., phytobiotics or botanicals), 
which are plant-derived substances have also been considered. In swine production, the two most 
common phytogenic substances are oregano and thyme. These substances are proposed to 
improve performance by increasing feed intake, improving gut function, and providing swine 
with anti-oxidative and antimicrobial effects (Jacela et al., 2010).  
 
FUNCTION OF PROBIOTICS IN THE GASTROINTESTINAL TRACT 
The roles of probiotics in the Gastrointestinal Tract (GIT) are numerous, including their 
beneficial role within the livestock industry (Cho et al., 2011). Positive effects of probiotics in 
animal feed could include: competition between probiotics and pathogenic (harmful) bacteria for 
gut nutrients, as well as for intestinal epithelium binding sites; stimulation of the immune 
system; and the ability for probiotics to produce toxic compounds that could incapacitate 
pathogenic bacteria (Cho et al., 2011). Furthermore, certain strains of probiotics are selected 
based upon specific criteria, which includes the microbial supplement having a high resistance to 
stomach acids and bile salts, thereby being able to colonize in the intestine (Verdenelli et al., 
2009). Healthy intestines colonized by beneficial microbes thereby enhance the ability of natural 
gut flora to fight intestinal infections (Hatoum et al., 2012). Therefore, feeding probiotics to 
animals may support the health of the existing microflora while also treating existing infections.  
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Probiotic yeast and bacteria work through different mechanisms, including stimulating 
growth and enhancing survival of good bacteria in the body. Probiotics can be used for several 
purposes—three of which will be highlighted here. First, digestive health is of importance due to 
its role in the balance and multiplication of beneficial microbial populations in the GIT 
(Gorbach, 1996). For example, the restoration of normal intestinal microflora after 
supplementation with the yeast probiotic, S. boulardii has been reported in past studies (Hatoum 
et al., 2012). Second, induction of the host response stimulates specific proliferation responses, 
which allows for probiotics to shape the immune system via physiological action in the 
intestines. Schierack et al. (2007) conducted an experiment in which the peripheral blood 
mononuclear cells in piglets (specifically, cytokine production) had an effect on vaccination 
responses. Bacillus cereus var. toyoi was shown to enhance systemic immune responses in 
piglets, due to changes in the ratios and functionalities of systemic immune cell population 
reported in the probiotic-treated animals. Third, probiotics aid in the inhibition of potential 
pathogenic bacteria, by producing substances that can inhibit Gram-positive and Gram-negative 
bacteria (Corcionivoschi et al., 2010).  
Ojeda et al. (2012) described the importance of the gut microbiota in both the mother and her 
offspring; particularly its role in metabolizing indigestible dietary components, which can impact 
obesity pathology. The chosen diet given to a female during gestation may influence whether her 
offspring become severely overweight during their early life, as well as affecting other 
physiological and behavioral traits. These products of fermentative digestion can either be 
utilized for energy, or even impact different host cellular processes. It is speculated that a high 
fat diet has the potential of altering the offspring’s epigenetic programming, which would result 
in inflammation. Moreover, fetuses of sows fed high fat diets during the gestational period may 
be at a higher risk of pathogenic bacterial infections (Ojeda et al., 2012). Upon weaning, the 
intestinal microflora of piglets is altered due to dietary changes and environmental challenges, 
allowing for probiotics to have a greater and more influential role at this time. In fact, the 
beneficial effects of probiotics occur in the weaned pig more than the grow-finish pig (Falaye et 
al., 2016). This could potentially offset colonization of negative strains such as the 
enterotoxigenic E. coli that expresses K88 fimbrial antigens, resulting in diarrhea and even death 




MATERNAL-FETAL PROGRAMMING IN SWINE PRODUCTION 
Given the concept of maternal-fetal programming in swine production, research should be 
focused on determining the ways in which producers and farmers can improve the well-being of 
the sow, by transferring her immune status and/or stress responsiveness to her offspring. By 
looking at various measures such as stress response, immune system, behavior, performance, and 
productivity, a better understanding of the biological consequences of these changes can be 
gained; thereby allowing research to be focused on the improvement and minimization of 
possible negative aspects of animal production. Further research is necessary in this field, as the 
GIT of the pig is comprised of not only a wide range of beneficial bacteria, but an array of 
harmful microorganisms as well (Hardy et al., 2013). This delicate balance of bacteria within the 
animal’s body has the propensity to shift during times of stress—especially during the weaning 
phase in piglets. The negative outcomes of not being able to control the spread of these harmful 
microorganisms could result in prolonged poor performance of the animal, or even consequences 
as severe as disease and/or mortality.  
In a research review conducted by Chu et al. (2016), maternal nutrition during pregnancy and 
lactation was evaluated in order to determine the possible effects on offspring gut microbial 
composition and function. It was hypothesized that both the maternal gut nutrition and the 
offspring gut microbes would have an influence on offspring physiology and susceptibility to 
disease later in life. Moreover, this highlights the significance of the pregnancy period as a time 
in which the neonatal microbiome is undergoing essential development. The main objective of 
the review was to interlink the gut microbiota model with that of the Disease Origins of Health 
and Disease (DoHaD) hypothesis, which states that “adverse in utero conditions can influence 
developmental pathways in early life that results in long-term changes to offspring disease 
susceptibility.”  
Maternal nutrition during pregnancy has a significant influence on microbiota abundance and 
its associated functions, as well as its impacts on the physiology of the host itself. Within this 
review, it was noted that the intrauterine environment of the pregnant female is not sterile; 
therefore, the maternal-fetal transmission of microbiota can occur during pregnancy. This differs 
from previous research, which assumed that the offspring’s first contact with microbiota occurs 
at the time of parturition. Therefore, the intrauterine environment is the key factor in determining 
fetal growth, with nutrition playing the most critical role in this process, and fetal genome also 
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altering these mechanisms. The organs that would be most affected by low birth weight (due to 
poor maternal nutrition) include the heart, liver, and spleen of developing offspring. This can be 
interpreted as the fetal programming of adult disease and reduced growth potential, with 
additional effects on neonatal growth, immune system maturation, neurodevelopment, and 
carcass quality (Chu et al., 2016).  
 “The maternal environment in which gilt fetuses develop plays a profound role in the 
development of the reproductive and other physiologic systems” (The Virginia Cooperative 
Extension, 2008). The formation of the placenta occurs at about day 18 post-fertilization of the 
ova. During this time (within the embryo), formation of the ectoderm, mesoderm, and endoderm 
have already occurred, allowing for cell specialization to continue. At 20 days post-mating, most 
of the major organs are established. Finally, during the last half of the gestational period, the size 
of the developing fetus rapidly increases (Estienne and Harper, 2008). Foxcroft and Town (2004) 
found that variation in growth performance after birth is actually pre-programmed during fetal 
development in utero. Furthermore, pre-programmed growth performance limitations can surface 
later in the production life of swine, even during the late grower or early finisher stages.  
Eckhardt et al. (2014) measured the effects of a high-energy diet in late pregnancy, and 
hormone therapy at weaning, in order to create a plasma metabolite profile and assess litter 
performance and reproduction. The goal of the study was to better understand the maternal plane 
of nutrition and body condition during late gestation, and its effects on embryonic development. 
Results for sow performance in this study found that animals fed higher-energy diets presented 
the greatest loss in body weight during lactation (P<0.05). Alternatively, results from the piglet 
study found that there were no differences in piglet development, with similar body weight loss 
or gain consistently seen between treatments throughout the study (Eckhardt et al., 2014).  
It is speculated that microbiota are capable of inhabiting the in utero environment, since the 
fetus may encounter exposure to bacteria for the first time during the gestational period, instead 
of at the time of parturition (Dong et al., 2015). Research shows that there are similarities 
between the neonate’s meconium and amniotic fluid, with that of the placental microbiota. This 
suggests that microbiota move across the placenta and into the intrauterine space during the 
maternal-fetal interaction (Dong et al., 2015). A study by Collado et al. (2008) found that obesity 
and gestational weight gain were a result of alterations in the gut microbiome during pregnancy. 
Because diet plays a role in the type and abundance of microbiota that is produced, the 
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transmission of microbial bacteria via mother to offspring would substantially affect both the 
establishment and development of a healthy neonatal microbiome. Therefore, the interactions 
between diet, pregnancy, and the microbiome would result in impacting both maternal and fetal 
health (Collado et al., 2008).  
Fetal programming and genomic imprinting are the bases on which nutrition in the 
intrauterine environment alters the expression of the fetal genome, leading to lifelong changes in 
the development of the offspring (Foxcroft et al., 2009). Genomic imprinting, which refers to the 
parent-of-origin-dependent expression of a single allele of a gene, further impacts fetal 
programming by means of maternal nutrition and metabolic state (Lawson et al., 2013). 
Therefore, determining the mechanisms of linking the maternal nutrition state to prenatal 
programming is needed to assess the relevance of nutrigenomics in the gilt and sow. Growth and 
development are two key aspects that should be assessed in the topic of fetal programming. For 
example, undernutrition of the fetus could affect both the health and performance of the 
offspring later in life (Weatherall et al., 2006). This means that maternal undernutrition, or even 
over nutrition, can have an effect on fetal and postnatal development, as it can reduce placental 
blood flow and stunt fetal growth. A study conducted by Blair et al. (2009) in which puberty in 
ewe offspring was assessed, and were later mated and a subset milked, showed how dam 
nutrition affects the yield and composition of milk in their offspring. Additionally, results of the 
study further indicated that dam nutrition can also affect the weight and reproductive capability 
of their grand-offspring. Depending on the species of animal, maternal malnutrition can reduce 
fetal growth, as well as protein and energy restrictions to offspring.   
Intrauterine growth restriction (IUGR), or runting as it is also called, can be exacerbated by 
both undernutrition and over nutrition during the gestational period (Ashworth et al., 2001). Runt 
fetuses are more prevalent in the largest litters in utero, and are partly related to uterine capacity 
for normal placental and fetal development. Nutrient deficiencies, including proteins and 
micronutrients, during the fetal growth phase increase the vulnerability of the developing fetus to 
a multitude of developmental consequences. In the case of swine, Wu et al. (2004) reported that 
there is a disproportionate supply of nutrients found along the uterine horn, which results in 15-
20% lower birth weight in piglets (<1.1 kg). Overall, this would severely affect growth 
performance, but more importantly, postnatal survivability. In maternal over nutrition, which 
involves an increased uptake of energy and/or protein, placental and fetal growth are at risk of 
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being restricted and causing mortality, especially in pigs (Wu et al., 2004). It has also been 




The main perceived threat to the use of antibiotics is the potential for resistant genes to be 
transferred to pathogenic bacteria. This is why yeast is of beneficial value, as the transfer of 
genetic material does not occur between bacteria and yeast. Yeasts contain nutrients such as 
enzymes (proteins), vitamins, and minerals that can be found in the enteric microflora of 
animals; furthermore, they are digestible and can be used for maintenance and production 
(Salyers et al., 2004). In pigs, probiotics improve growth performance, digestibility, and 
immunity. Increased nutrient uptake could improve the growth performance of the animals, via 
the feed additives’ effect on the permeability of the gut (Baum et al., 2002). In cattle, yeast single 
cell protein can be used to accelerate the growth and improve well-being via rumen acetogen 
stimulation (Hatoum et al., 2012). Supporting research by Chiquette (2009), found that feeding S. 
cerevisiae to ruminants resulted in stabilization of the rumen pH, as well as prevention of 
acidosis (caused by rapid fermentation of large quantities of carbohydrates). Feeding yeast to 
animals allows for the stimulation of rumen microbial growth and oxygen, which allows for 
anaerobic microorganisms to persist in more favorable conditions (Chiquette, 2009). However, 
as has been stated previously, the mode of action of probiotic yeast in the rumen depends on 
yeast strain, viability, and diet composition.  
The stability of probiotics as feed additives would have to prove dependable in terms of 
longevity when considering factors including: shelf life under storage conditions, survival 
through feed processing, animal ingestion, and surviving the animal’s gastric barrier (Soccol et 
al., 2010). Commonly-used feed processing technologies have been found to kill probiotic 
cultures. Therefore, identifying the most suitable microbial strain is the first step in developing a 
probiotic for pigs that will garner a specific and more reliable effect within the swine production 
industry. Keeping in mind that not all probiotics work as effectively (or at all for that matter) 
with all pigs, the physiology of a pig needs to be considered in order to measure the reliability 
and consistency of the probiotic. Probiotic products must also be economical and produce 
measurable improvements in welfare and production. 
12 
 
In general, probiotics defend the cells of the body by receiving anti-inflammatory cytokines, 
while reducing proinflammatory cytokines from both enterocytes and intestinal immune cells 
(Cho et al., 2011). Stavric and Kornegay (1995) suggest that during microflora development, and 
also when microflora stability is impaired, probiotics prove to be the most effective. 
Supplementation of probiotics such as L. sobrius, for example, has been found to suppress 
pathogen levels and improve overall performance of weanling pigs that were affected with E. 
coli (Konstantinov et al., 2008). Adding probiotics to pig diets has been found to increase 
fermentative activity, while simultaneously stimulating digestion. In addition, lactobacilli are 
capable of colonizing in the GIT epithelium, thereby developing a protective membrane to 
combat harmful pathogenic microorganisms, while also stimulating epithelial lymphocytes (Yu 
et al., 2008; Hou et al., 2015). 
Research conducted by Perry (2014) was the first to publish research regarding the use of 
probiotics in high-fiber diets; to increase fiber fermentation rates while reducing manure output. 
The high-fiber diets given to the tested pigs contained 10% soybean hulls and 20% corn DDGS, 
which were then supplemented with one of three bacterial supplements comprised of different 
strains of Bacteroides ovatus. The probiotic designated Bacterium B resulted in pigs with a 20% 
reduction of manure output, increased weight gain, improved blood cholesterol, and improved 
glucose levels. These outcomes enhanced overall energy status, while increasing producer profits 
and reducing the environmental impact of pork production (Perry, 2014). Similarly, research 
conducted by Bhandari et al. (2010) demonstrated how probiotics, coupled with a low protein 
diet could increase the overall performance of weanling pigs, resulting in improvement in growth 
rate and reduction of pathogenic bacteria.  
A European efficacy study (Jorgensen and Hansen, 2016), utilizing gilts and sows on a 
commercial farrow-to-finish pig farm, supplemented the diet of sows with probiotic BioPlus2B 
two weeks prior to the farrowing-to-weaning phase. The study found a 42% reduction in pre-
weaning mortality for the piglets of sows administered the designated probiotic. Additionally, 
there was an increase of about one piglet born and weaned per treated sow/year overall. The 
probiotic group also had an improved diarrhea score, as well as piglets having a 5% greater 
weaning weight than the control group. In terms of the effects of the probiotic BioPlus2B on the 
treated sows, there was an average of about 21% lower body weight loss during the lactation 
period (Jorgensen and Hansen, 2016).   
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SACCHAROMYCES CEREVISIAE BOULARDII 
Saccharomyces cerevisiae boulardii (Scb) is non-pathogenic yeast used in human medicine 
to both prevent and treat intestinal disorders, including infectious and antibiotic-associated 
diarrhea (Llopis et al., 2014). Scb belongs to the group of simple eukaryotic cells (i.e., fungi and 
algae), which is why it is different from bacterial probiotics, which are prokaryotes. It is unique 
in its ability to survive in the GIT (with an optimal temperature of 37 degrees Celsius) while 
simultaneously inhibiting microbial pathogens (Llopis et al., 2014). The gastrointestinal 
microflora, or microbiota as it is also called, coexists in equilibrium with the host. A probiotic 
must be able to withstand the host’s natural barriers to ingested microorganisms, so that they 
may be viable and biologically active microorganisms at the target site. It is essential that these 
probiotics be resistant to local stresses, including the presence of GI enzymes, stomach acids, 
bile salts, pancreatic juices, organic acids, and variations in pH and temperatures (i.e., thermo-
tolerant) (Czerucka et al., 2007). These probiotic supplements must adhere to the internal 
epithelium, while also stabilizing the balance of gut flora. Microbial colonization is dependent 
upon the number and species of bacteria due to environmental conditions (Czerucka et al., 2007). 
In microbial ecology, yeast are a part of the microflora making up <0.1% of microbiota.  
Product background studies have been conducted by Lallemand Inc. (Canada) in which the 
yeast probiotic, Scb, was supplemented in sow diets during the peripartum (in intestinal transit) 
and farrowing periods. These studies found that upon product administration, the probiotic-
supplemented diet is capable of maintaining a healthy and balanced gut microflora in the sow. 
Additional benefits to the sow include colostrum and milk production/quality improvements, 
which directly affects the sows’ piglets as well. Piglet benefits included reduced neonatal 
diarrhea and mortality (at birth and during lactation). Piglets were found to be stronger and more 
active (i.e., higher energy level) at birth, with continued improved growth development and 
performance during the lactation phase (Lallemand Animal Nutrition, 2011). Lallemand Inc. has 
indicated that strain-specific yeast and bacteria probiotics positively influence the digestive 
function and balance (throughout the animal’s life), including the health of food production 
animals treated with the feed additive. More specifically, the benefits of incorporating probiotics 
into the diet of food animals include: enhancement of rumen/gut function, digestibility 
improvement, and protection against harmful bacteria (Lallemand Inc., Canada).  
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There are many purported benefits of feeding S. boulardii (Sb), as it may directly or 
indirectly suppress populations of potentially pathogenic or growth-suppressing microorganisms. 
Additional benefits, depending on the animal model used, as previously described by Collier et 
al. (2014), include: production of trophic factors to increase gut-associated lymphoid tissue-
derived IgA production, improved mucosal barrier function, and improved brush border 
membrane integrity. For example, in vitro, it has also been found that Sb can stimulate the 
digestion of cellulose and promote the utilization of lactate (Qamar et al., 2001), by stimulating 
an increase in intestinal IgA secretion in mice when challenged with C. difficile toxin A. Results 
showed that Sb can be used against C. difficile infection, because the probiotic binds the 
pathogen in order to deactivate the bacteria and inhibit attachment to the epithelium. Another 
study that added Sb to diets found improved immune defenses, digestion, and absorption of 
nutrients (Buts and de Keyser, 2006). A considerable amount of polyamines can be found in Sb, 
and is said to be a mediator of trophic effects (Fioramonti et al., 2003). Important physiological 
effects of these polyamines include: cell maturation, enzyme expression, and membrane 
transport mechanisms (Buts et al., 1994). Finally, studies conducted on the effects of Sb in 
poultry have found in increase in bird weight when their feed was supplemented during the early 
stages of life. This is due to the fact that whole yeast improved the growth rate, meat tenderness, 
and oxidative stability in the animal (Zhang et al., 2005). 
Research conducted by Lipinski et al. (2012) found positive effects of the probiotic yeast, 
Scb, on the reproductive performance of pregnant and lactating sows when supplemented into the 
animals’ diets. For the purposes of the research indicated, the strain Levucell SB 10 was used to 
determine the health status and productivity of both the sows and their respective litters. Using a 
total of 243 gilts and sows, which included the 125 untreated control animals, treatment spanned 
from day 1 of gestation to day 28 of lactation. The results of the experiment found that sows 
(noted initially as having a poor health status) fed a diet that included the probiotic supplement, 
had better fertility and mating effectiveness compared to the control group sows. Moreover, the 
sows that had poor health prior to receiving the probiotic supplement benefited from the 
probiotic once the treatment began, as the sows’ reproductive problems (including abscesses and 
abortions) improved over time in accordance with being fed the supplement. However, it was 
also noted that sows fed the probiotic supplement did not change the condition or the length of 
their parturiency (Lipinski et al., 2012).  
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It has been noted in some studies that supplementation of Scb did not modify the intake and 
digestibility of dry matter, organic matter, EE, and CP. First, Kimse et al. (2012) concluded that 
adding live yeast to the diets of rabbits did not modify the total digestibility of nutrients. Second, 
it was found that oral administration of yeast culture did not have an effect on the digestibility of 
nutrients in diets with different fiber content (Chaudary et al., 1995), although past research has 
found that Sb can cause an increase in secretory IgA. Lastly, Oso et al. (2013) reported that ADF, 
NDF, and other nutrient digestibility values were unaffected by the addition of probiotics of 
bacterial origin into the diets. 
A study conducted by Collier et al. (2011), evaluated the effects of active dry yeast, Scb, on 
the immune and cortisol response was assessed in newly weaned piglets. The objective of the 
study was to determine whether oral administration of Scb reduces mortality of newly weaned 
piglets as it is associated with immune and cortisol responses to Escherichia coli endotoxin. It 
was hypothesized that before challenging the piglets (at weaning), a beneficial immune and/or 
neuroendocrine interaction profile would be established, thereby resulting in acute responses to 
pathogenic challenges in order to prevent the diversion of energy (i.e., used for growth-
promotion instead). Results of the study indicated that mortality rates in LPS-induced piglets 
were reduced by 20%. In Scb-treated animals, prior to LPS dosing, there was an increase in 
white blood cells, lymphocytes, and neutrophils. This suggests that Scb-induced immune-
neuroendocrine LPS response thus functions to facilitate short-term prevention of the pathogen. 
Within this study, Scb-treated pigs not only had reduced LPS-induced mortality, but increased 
average daily gain as well. Scb supplementation to newly weaned piglets resulted in differential 
cytokine production profiles that were taken from a larger pool of immune cells. Therefore, in 
vitro, Sb may alter the signaling pathways that were once implicated in proinflammatory 
cytokine synthesis. This was in the presence of reduced cortisol concentrations, before and 
during the LPS challenge response. With the potential of Scb to prevent LPS-induced mortality, 
benefits related to animal growth are promising across a multitude of animal models (Collier et 
al., 2011). In conclusion, Sb was found to have a unique immune/cortisol profile, with effects 
that are similar to the use of subtherapeutic antibiotics. 
 
PIGLET WEANING PHASE 
16 
 
The first weeks of life constitute the most critical period for piglets, since they can be 
exposed to conditions that negatively influence neonatal immune responses, thereby 
compromising their ability to resist and combat pathogenic challenges (Tuchscherer et al., 2002). 
Factors such as environmental stressors, husbandry practices, and antigenic exposures of sows 
each may negatively affect the early development of the piglet’s immune system, with a probable 
increase in susceptibility to infection or disease, and a reduction in growth and performance. 
Moreover, prenatal maternal stress during late-gestation reportedly impairs the development and 
reactivity of the immune system of a sow’s offspring and impacts the frequency of disease and 
mortality (Tuchscherer et al., 2002). 
At weaning time, piglets make the transition from liquid feeding (i.e., milk) to dry feeding, 
with the potential for digestive upset. In order to reduce the colonization or presence of 
pathogenic bacteria like Salmonella within the intestine, competitive exclusion of pathogenic 
bacteria by non-pathogenic microbes is a feeding option (Steer et al., 2000). Probiotic use in 
swine production has been found to improve gut microbiota balance, integrity of the intestinal 
epithelium, and maturation of gut-associated tissue (Hemarajata and Versalovic, 2012). The most 
commonly used probiotics are said to be bacterial-derived species. Coming from either the genus 
of Bacillus or Streptococcus, a mixture of these two probiotics has been reported to improve both 
average daily gain and feed conversion ratio in piglets subjected to weaning and mixing stress 
(Taras et al., 2005 & 2006).  
In a study by Jorgensen and Hansen (2016), the weaning phase was pinpointed as the most 
traumatic event that piglets will be subjected to upon leaving the nursery (and in their life in 
general). It is in the first three weeks of a piglet’s life that its GIT is under continuous 
development, yet still measurably immature, while the gut flora are being established. The 
transition phase (identified here as the first week after weaning) occurs when the highly stressed 
GIT and the maturing immune system are delicately interacting. Possible negative effects of this 
interaction during the transition phase include challenges to the sub-clinical disease status of the 
piglet. This could result in reduced feed intake, as well as increased illness and mortality, since 
gut microflora have “stimulating and/or depressing” effects on one another. The interaction of 
the gut micro-flora on the host animal differs depending on many factors, including age, feed 
consumption, stress level, and the environment (Jorgensen and Hansen, 2016).  
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Gastrointestinal disorders occur most prevalently immediately post-weaning. In a study 
conducted by Baum et al. (2002), weaned pigs were administered the live yeast, Scb, for a period 
of 3-4 weeks. This study found improvements for post-weaning growth performance, villus 
height, epithelial cell proliferation, and macrophage count at multiple sites within the small 
intestine. The incidence of diarrhea in piglets during the first week post-weaning was reduced 
when sows were fed Escherichia faecium. Moreover, the level of cytotoxic T-cells in the jejunal 
epithelium of these piglets was also reduced. Similarly, gastrointestinal disorders influenced by 
the physiological state, were assessed post-birth in the digestive tracts of piglets. It was reported 
that colonization of useful microorganisms (i.e., lactic acid bacteria, Enterobacteriaceae, and 
Streptococcus) occurred via contamination from the maternal environment, including increased 
numbers and density of anaerobes (Zoetendal et al., 2004). This newly created microbiota can 
then protect against pathogens due to defense at the mucosal level. 
Giang et al. (2010) conducted a 35-day feeding trial in which weaned piglets were given a 
feeding trial that was supplemented with 0.2% yeast and a mixture of lactic acid bacteria. The 
results of this study suggest that the administered diet improved the total tract digestibility of 
crude protein, crude fiber, and organic matter. The mixture of lactic acid bacteria complex, along 
with Sb, helped to improve overall performance of the animal, since no growth parameters were 
thus affected by live yeast addition. S. boulardii further aided in increasing the concentration of 
short-chain fatty acids, as well as in populations of lactic acid bacteria (LAB). The increased 
content of organic acids acidifies the intestine and exerts an antibacterial effect. Piglets fed LAB 
had reduced incidences of diarrhea; additionally, average daily feed intake and average daily 
gain were increased, with a lower feed conversion ratio. Since yeast probiotics can cause 
proliferation of LAB, thereby having an effect on inflammation in the intestinal tract, this can 
potentially lead to secretion of immunosuppressive cytokines (i.e., IL-10). The utilization of Sb 
in this study was beneficial, as weaning stress is capable of decreasing good bacteria, while 
increasing the population of E. coli, thereby increasing susceptibility to disease (Giang et al., 
2010).  
A study of the effects of injectable antibiotics and a probiotic on suckling pigs (including 
growth and death loss) administered within 24-hours post-farrowing; and the effects of a 
probiotic on nursery pig performance administered at weaning, was conducted by Estienne et al. 
(2005). The objective of the first experiment was to specifically determine the effects of various 
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antibiotics (i.e., oxytetracycline, erythromycin, penicillin G procaine, and tylosin) and probiotics 
(i.e., lactobacillus and streptococcus) on suckling pig performance (pig body weights and 
survival during pre-weaning period), which were given within 24-hours post-farrowing. The 
study found that the sows treated in this experiment did not have different piglet survival rates 
from birth-to-weaning, nor did the groups have different body weights (i.e., birth, 7-day, 14-day, 
and 21-days of age) when compared to the control group. The second experiment of this study 
determined the effects of the probiotics lactobacillus and streptococcus on nursery pig 
performance (growth performance) which was given at the time of weaning. Here, the use of 
probiotic feed additives did increase average daily gain and feed consumption of non-littermate 
weaned pigs. Overall, the inclusion of antibiotics or probiotics in the sows’ diets benefited pre-
weaning performance (Estienne et al., 2005). It was suggested that if therapeutic antibiotic 
injections are to be used in the food animal industry, that it should be limited to use for specific 
disease-treatment scenarios.  
 
CONCLUSION 
The previous research cited within clearly demonstrates the impact that maternal nutrition 
has on the offspring gut microbiome. This interaction could potentially occur in utero in certain 
species, as well as beyond pregnancy, into the postnatal period and throughout lactation. 
Maternal diet, during pregnancy and throughout lactation, affects the microbiota by potentially 
changing the abundance and type of bacteria that can be transferred from mother to offspring 
during the periods of gestation, and even in the early life of offspring (Nuriel-Ohayon, 2016). A 
potential mechanism of great importance to this topic is the microbial transmission across the 
maternal-fetal interface within the placenta. Furthermore, a clear understanding of the sow’s 
metabolic status throughout pregnancy is crucial to defining the specific maternal-fetal 
interactions that occur in utero and during the early life of offspring (pre-weaning phase). 
Further research as it relates to a variety of species models include, but are not limited to, the 
following: maternal and neonatal nutrition (i.e., energy, protein, etc.), number of fetuses, 
maternal age, maternal environmental stress, and maternal and fetal genotype (Langley-Evans, 
2006). Favorable traits for litter quality include ovulation rate, embryonic and fetal survival, and 
enhanced uterine capacity. Hence, the avoidance of prenatal programming of undesirable litter 
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phenotypes will ensure improved lifetime performance of the offspring selected for breeding in 
future practices. (Langley-Evans, 2006). 
Past research has reported both benefits and drawbacks of incorporating probiotic feed 
additives into animal agriculture operations (either as a supplement to, or in replacement of, 
antibiotics). Factors include: the low survival rate of strains, interactions with other medicines 
including antibiotics and antimicrobials, insufficient (or low) probiotic dosages, possible 
stressors it induces or alleviates on the animals, varying stabilities of strains, differing animal 
genetics, frequency of administration, health and nutritional status of the animal, etc. (Cheng et 
al., 2014). As suggested in a review by Turner et al. (2001), the specific production environment 
significantly influences the growth performance of pigs. Even when food animals are given 
performance-enhancing agents though, factors such as the cleanliness of the facility, the history 
of disease on that specific housing location, and the overall health status of the current group of 
animal housed there, can result in adverse effects for the animals being raised for human 
consumption (Turner et al., 2001). Criteria for effective strains of bacteria (e.g., probiotics) that 
are selected include the supplement having a high resistance to stomach acids and bile salts, as 
well as being able to colonize in the intestine (Cho et al., 2011). 
Human health, animal health, and the environment are three key areas that must be 
considered when evaluating long-range planning to limit antibiotic resistance. As quoted by Dr. 
Robin Ganzert (CEO of American Humane Association, American Humane Certified program), 
“An outright ban [of antibiotics] would be inhumane to sick animals, and would violate one of 
the five freedoms (freedom from pain, injury or disease) that serves as the internationally 
accepted social contracts with animals” (Ganzert, 2015). In the food animal industry, both 
socioeconomic and health related issues are important factors driving the discussion of this topic, 
and must therefore be at the forefront of creating viable solutions to the perceived problem of 
continued antibiotic use in food animals. It is likely that the most viable option in this debate 
would be the partial replacement of antibiotic growth promoters, such as supplementing the use 
of both antibiotics and probiotics as feed additives in the diets of swine. Hence, determining how 
probiotic feed additives that are supplemented into that of the sows’ diets impacts not only the 
health and overall performance of these sows, but that of their piglets (especially during the 




CHAPTER 2. THE EFFECTS OF FEEDING PROBIOTIC, SACCHAROMYCES 
CEREVISIAE BOULARDII, TO SOWS DURING GESTATION AND THROUGH 
LACTATION ON IMMUNE AND CORTISOL RESPONSES TO FARROWING AND 
WEANING STRESS  
 
INTRODUCTION 
Feeding antibiotics to healthy food animals has become a global concern due to the increased 
occurrence of antibiotic resistant bacteria. A potential alternative to consider is the use of 
probiotics. Probiotics are microorganisms that, when ingested in adequate amounts, confer health 
benefits on the host (Czerucka et al., 2007) possibly by restoring the composition of the gut 
microbiome and reducing gut inflammation (Hemarajata and Versalovic, 2012). Evidence exist 
suggesting that bacterial probiotics (i.e., Lactobacillus) can non-specifically modulate the host 
immune system by enhancement of phagocytic activity (Roessler et al., 2008). But, probiotics 
have also been shown to have immunosuppressive properties by suppressing inflammation, 
primarily through disrupting pro- and anti-inflammatory cytokines. Specifically, Saccharomyces 
cerevisiae boulardii (Scb) has been shown to block the secretion of inflammatory cytokines, e.g., 
IL-8 and IL-6, which are released in response to infection (Dalmasso et al., 2006).   
Most research conducted on feeding the probiotic Scb to swine has been in piglets. Feeding 
probiotics to piglets during lactation reduces the incidence of pathogen-induced diarrhea post-
weaning by preventing adherence of pathogens to the intestinal wall and neutralizing bacterial 
endotoxins (Perdigon et al., 2002; Gad et al., 2011). Early studies conducted by Lallemand Inc. 
(France) found that there were benefits to supplementing food animal diets with Scb which 
included: enhancement of gut function, digestibility improvement, and protection against 
harmful bacteria (Chevaux and Guillou, 2015). More specifically, the use of Scb supplemented in 
sow diets during the peripartum (in intestinal transit) and farrowing periods is capable of 
maintaining a healthy and balanced gut microflora and improvement in colostrum and milk 
production/quality, which directly affects the well-being of her piglets. Thus, if the benefits of 
probiotics are also transferable from dam to piglets, probiotics may be a viable option for both 
the sow and her offspring. It is hypothesized that pregnant sows fed the yeast probiotic treatment 
(PRO-sows), Scb, during late gestation will have an overall improved immune status and cortisol 
levels. Treated sows will also have greater innate and adaptive immune measures when 
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compared to the control sows (CON-sows) during the gestation and lactation periods. Therefore, 
the objectives of this research were to evaluate the effects of feeding a yeast probiotic, Scb, to 
pregnant sows during late gestation (d 84 – d 112 of gestation) and a three-week lactation period 
(d 115 – d 135) on innate and adaptive immune status of the sow and the effects of farrowing and 
weaning stresses on immune and stress responsiveness. 
 
MATERIALS AND METHODS 
Animals and Experimental Design 
All procedures were approved by the University of Illinois and the Institutional Animal 
Care and Use Committee (IACUC). A total of eighteen pregnant sows, derived from the 
Genetiporc maternal line, were used in this study. Sows were all parity two, and vaccinations 
were used following farm standard operating procedures and health plan. The experiment was 
conducted across two phases of production (gestation and lactation). Days of gestation (phase 
one) included d 84 (baseline: began feeding placebo or yeast probiotic boluses to sows; d 0 of 
treatment), d 91 (d 7 of treatment), d 98 (d 14 of treatment), d 105 (d 21 of treatment), and d 112 
(sows moved into farrowing crates on this day; d 28 of treatment). This resulted in a four-week 
gestational treatment period, with immune and blood measures being collected every seven days. 
Days of lactation (phase two) included gestational day 112 (baseline: sows moved into farrowing 
crates on this day; d 28 of treatment), and days 115 (24-hours post-farrowing; d 31 of treatment) 
and 135 (weaning; d 51 of treatment).  
Sows were randomly assigned to either the control treatment (CON-sows) or the 
probiotic treatment (PRO-sows) starting on d 84 of gestation (baseline for the experiment). Sows 
were maintained in treatment groups (CON or PRO sows) throughout the study (n = 18 sows; 9 
sows/treatment). Either the placebo or the probiotic boluses were fed daily starting on d 84 of 
gestation and ending on day of weaning of sows (d 135). Day 84 of gestation was chosen as the 
first day of treatment based on data that supports pig fetus immune cell development, and was 
also recommended by Dr. Ken Mellits at the University of Nottingham. In utero, research 
conducted by Salmon (1984) states that the pig fetus becomes immunocompetent at around 80 
days of fetal life, which is indicative of the immune cell development that is of particular interest 
to this study. In addition, d 90 of gestation coincides with all other work from the Salak-Johnson 
laboratory for sow immune status.  
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Sows were hand-fed either two boluses of CON or PRO every morning at 0700 h. The 
probiotic bolus contained 2.0 x 10
9
 (CFU/g) of Saccharomyces cerevisiae var. boulardii (Scb) 
CNCM I-1079 per bolus (Lallemand Inc., Canada). Scb is noted as being non-toxic and harmless 
to humans and animals, and has no withdrawal period. The control bolus was sugar based, and 
anatomically the same shape and size as the probiotic bolus.  
Gloves were worn at all times during the feeding of placebo and probiotic boluses to 
prevent residue transfer. To avoid the possibility of cross contamination from the probiotic bolus, 
the CON boluses were always fed to the nine control sows first. Gloves were discarded and 
hands were washed after feeding the control sows. Then, the PRO boluses were fed to the nine 
treatment sows. Again, gloves were discarded and hands were washed after each daily feeding of 
the probiotic boluses. 
 Sows were individually fed a diet formulated to meet or exceed established nutrient 
allowances (NRC, 2016). During gestation, each sow was fed 2.5 kg/d of corn-soy based diet 
having a calculated composition (as fed) of 12.5% CP and providing a calculated ME density of 
3,300 kcal/kg. All sows were fed between 0700 and 0730 h each day. Each stall was equipped 
with one nipple waterer. Lactating sows were fed ad libitum, a corn-soy based diet with a 
calculated composition (as fed) of 16% CP and 3,426 of ME/kg.  
 
Housing 
Sows were housed at the University of Illinois Swine Research Center in Urbana-
Champaign. During gestation, sows were housed in standard gestation stalls (2 ft. x 7 ft.) in a 
mechanically-ventilated, insulated gestation building. On day 112 (± 2 days) of gestation, sows 
were moved to farrowing rooms, and kept in farrowing stalls, where they stayed until the end of 
the lactational period (d 135). All sows were kept on a 10 h light: 14 hour dark schedule, in 
which lights were on at 0700 h and turned off at 1700 h.   
 
Blood Sample Collection and Leukocyte Differentials 
Sows were nose-snared, and 10 mL of blood was collected via jugular venipuncture with 
vacutainers containing sodium heparin or EDTA (the procedure lasted <2 min) at gestational d 0 
(gestational d 84), 7 (d 91), 14 (d 98), 21 (d 105), and 28 (d 112); and then again at 24 h post-
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farrowing (d 115) and weaning (d 135). All control sows were bled first and then the probiotic-
treated sows.  
Heparin-treated whole blood was used to determine total white blood cell (WBC) counts 
and leukocyte differential counts (DIFF). Total WBC counts were made electronically using a 
Coulter Z1 particle counter (Beckman Coulter, Miami, FL). Ten microliters (10 μl) of whole 
blood was added to 10 mL of Beckman Coulter, Isoflow®, red blood cells were lysed with 
Beckman Coulter lytic reagent, ZAP-OGLOBIN® and then samples were placed in the counting 
chamber to determine total BBC count. To determine DIFF percentages, whole blood smears 
were made, fixed in methanol, and then stained with Hema-3 staining system (Fisher Scientific, 
Houston, TX). Slides were viewed under a light microscope, and 100 cells per slide were 
visually counted.  
 
Cell Isolation and Plasma Analysis   
Whole blood was collected and centrifuged at 700 × g for 30 min at 4℃. Plasma was 
aspirated and transferred to Eppendorf tubes and stored at -80°C until further analysis. Whole 
blood was diluted with Roswell Park Memorial Institute (RPMI; Gibco, Carlsbad, CA) medium, 
layered over Histopaque-1077 (density = 1.077g/mL; Sigma) and -1119 (density = 1.119 g/mL; 
Sigma), and centrifuged at 700 x g for 30 min at 25°C. Lymphocytes were removed from the top 
of the second layer and neutrophils from the top of the third layer. Red blood cells were lysed 
from the neutrophil fraction, which was then washed in RPMI and counted. Cell concentrations 
were adjusted with RPMI based on the immune assay requirements. Whole blood was diluted 
using Roswell Park Memorial Institute (RPMI) media.  
Plasma cortisol and IL-12 were analyzed following manufacturer’s protocols. 
Commercial radioimmunoassay validated for porcine cortisol was measured. Plasma samples 
from heparin-treated whole blood were assayed for CORT using a Coat-A-Count cortisol kit, 
following the manufacturer’s protocol (Diagnostic Products Corp., Los Angeles, CA). Briefly, in 
duplicate, 25 µL of sample or standard were added to antibody-coated tubes. Radiolabeled (I125) 
CORT was added to tubes and incubated for 45 min at 37°C in a water bath. The liquid phase 
was decanted and radioactivity counted with a gamma counter. A standard curve based on 0, 10, 
50, 100, 200, and 500 µg/mL was used. Intra- and inter-assay CV were 7.0 and 16.5%, 
respectively. Minimal detectable concentration of CORT using this assay was approximately 2 
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ng/mL. Porcine IL-12/IL-23 Quantikine kit was used to measure IL-12 in plasma samples (R & 
D Systems, Minneapolis, MN). Minimal detectable concentration of IL-12/IL-23 using this kit 
was on average 9.0 pg/mL.  
 
Immune Assays 
 Neutrophil chemotaxis was measured using an assay previously described by Salak-
Johnson et al. (1993). Neutrophils at a concentration of 3 x 10
6 
cells/mL were used in order to 
evaluate the ability of cells to migrate toward, (a) assay medium, with the control being random 
migration, or (b) recombinant human complement -5a (1 x 10
-7 
M) and recombinant human IL-8 
(100 μg/mL) with chemotaxis being directed migration in this case. Neutrophil phagocytosis 
measurements were gathered using a flow cytometry-based assay previously described by 
Heinzelmann et al. (1999), along with slight modifications described by Niekamp et al. (2006). 
First, fluorescent beads along with heat-inactivated porcine serum, were pre-incubated together 
for thirty minutes. Next, beads were added to the samples at a 10:1 ratio (beads: neutrophils). 
Finally, both cells and beads were incubated for forty-five minutes at room temperature. Flow 
cytometry allowed for the total percentage of beads that were engulfed by cells to be evaluated.  
 Using Promega CellTiter®, a colorimetric method for determining the number of viable 
cells in proliferation, cytotoxicity, and chemo sensitivity assays, with slight modifications 
described by Sutherland et al. (2005), a mitogen-induced lymphocyte proliferation assay was 
performed. First, lymphocytes from the sow were used at a concentration of 5 x 10
6 
cells/mL, 
and placed in a sterile 96-well flat-bottom plate (sample run in triplicate per sow). Concanavalin 
A (ConA) and lipopolysaccharide (LPS), both acquired from Sigma Aldrich, were used as 
mitogens in order to stimulate T and B cells. ConA and LPS were both used at measurements of 
0.2, 2.0, and 20 μg/mL. Plates were incubated for sixty-eight hours at a temperature of 37℃ in a 
5% CO2 humidified incubator. Next, 15μL of Promega Dye was added to each well, and the 
plates were incubated for an additional four hours. Promega Stop solution (100 μL) was added to 
each well, and the plates were incubated overnight at a temperature of 37℃. Finally, using BIO-
TEK Instruments® microplate reader at a wavelength of 550 nm with reference wavelength 690 





Optical Density (550/690 nm) stimulated cells 
PI = 
Optical Density (550/690 nm) non-stimulated cells 
 
 A nonradioactive cytotoxicity detection kit acquired from Roche Diagnostics®, also 
described previously by Sutherland et al. (2005), was used to measure natural killer (NK) cell 
cytotoxicity. First, sow lymphocytes were used as effector cells, while K-562 chronic human 
myelogenous leukemia cells (American Tissue Type Culture Collection, Manassas, VA) were 
used as target cells. Lymphocytes were adjusted to 1 x 10
7 
cells/mL, and K-562 cells were 
adjusted to a constant 10,000 cells per wall. Second, samples were run in triplicate at effector to 
target-cell ratios of NK 12.5:1, 25:1, 50:1, and 100:1. Third, plates were read using BIO-TEK 
Instruments® microplate reader at a wavelength of 490 nm with reference wavelength 690 nm, 
after an eighteen hour incubation period. Finally, percent cytotoxicity was calculated as 
previously described by Lumpkin and McGlone (1992). An assay was thus considered valid as 
long as the maximum release, divided by spontaneous release, was ≤ 20%.  
 
Sow Body Weight 
Sow body weight for this study was recorded on d 84 of gestation (baseline) and on d 135 
end of lactation (weaning). For this study no other body weight measures were taken in an 
attempt to minimize additional stress on the sows during gestation and lactation.  
 
Fecal Enumerations 
 Both fecal samples and blood samples were collected on the same days; on gestational 
days 84, 91, 98, 105, and 112, as well as on lactation days 115 (24 hours post-farrowing) and 135 
(weaning). This additional test was done in order to confirm that the nine control sows did not 
ingest a significant amount (if any at all) of the probiotic that would be needed in order to 
maintain a colony in the GI tract. Yeast fecal enumerations, obtained via rectal palpation, were 
conducted via standard methods using Rose Bengal Chloramphenicol Agar produced by Oxoid 
Limited®. The initial 10:1 dilution was made by adding 9 volumes of Maximum Recovery 
Diluent (MRD) of the original sample weight. Serial dilutions thereafter made with MRD, by 
putting 100 μL into 900 μL. Next, 100 μL was plated (using the spread plate method) onto 
duplicate agar plates in two different concentrations, 1 x 10
1 
and 1 x 10
9
. After the RBC agar 
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plates were incubated aerobically for a period of three days at a temperature of 30℃, then the 
plates could be read. Positive identification was based upon the typical colony morphology of 
Saccharomyces cerevisiae var. boulardii control stain. Results of this test (at the seven specified 
sample dates) showed yeast colonies were only successfully grown on RBC agar that were 
streaked with samples collected from the nine probiotic treatment sows, thus ensuring that there 
were no implications of cross-contamination in this study. 
 
Statistical Analysis 
 Data were analyzed using PROC MIXED with repeated measures SAS (SAS Inst. Inc., 
Cary, NC), mixed linear models contained both fixed- and random-effects parameters. Baseline 
days 84 and 112 of gestation were used as covariates when values were reported as significant.  
The first set of data was analyzed for gestational d 0 (baseline; gestational d 84), 7 (d 91), 14 (d 
98), 21 (d 105), and 28 (d 112) days post-treatment. The second set of data was analyzed for 
gestational d 28 (baseline; d 112), including lactational days 115 (24 h post-farrowing) and 135 
(weaning of sows). All traits were tested for departures from a normal distribution. The model 
included fixed-effects parameters of treatment, control or probiotic, as well as day of gestation 
for sows. In addition, random effect of parity was evaluated for sows. Significance of data was 
set at (p ≤ 0.05), and trends were also discussed at (p > 0.05) to (p ≤ 0.10). 
 
RESULTS 
Experiment 1: Treatment x Day Effects during the Gestation Period 
During gestation, at d 7 and d 14 post-treatment (d 91 and d 98 of gestation), CON-sows had 
lower plasma cortisol than did PRO-sows; while at d 21 post-treatment (d 105 of gestation), 
PRO-sows had lower plasma cortisol than did CON-sows (p = 0.002). At d 28 post-treatment (d 
112 of gestation), both CON and PRO sows had similar plasma cortisol concentrations (Figure 
2.1). 
 
Leukocyte Differentials. At d 7 and d 28 post-treatment (d 91 and d 112 of gestation), PRO-sows 
had greater percentage of eosinophils than did CON-sows (p ≤ 0.05). At d 14 and d 21 post-
treatment (d 98 and 105 of gestation) CON-sows had greater eosinophils (Table 2.1). Banded 
neutrophils (immature) were greater in CON-sows at d 7, 14, and 28 post-treatment (d 91, 98, 
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and 112 of gestation), but by d 21 post-treatment (d 105 of gestation), PRO-sows had greater 
percentages of banded neutrophils (Table 2.1). Segmented neutrophils were greater in PRO-sows 
during gestation at days 7, 14, and 21 post-treatment (d 91, 98, and 105 of gestation), while at d 
28 post-treatment (d 112 of gestation), CON-sows had greater percentages of segmented 
neutrophils (Table 2.1). Across all days of treatment during gestation, CON-sows had greater 
percentages of lymphocytes than did the PRO-sows (Table 2.1). Percentages of monocytes were 
greater for PRO-sows during gestation at all days post-treatment (d 14, 21, and 28); except for d 
7 post-treatment (d 91 of gestation), CON-sows had greater percentage of monocytes (Table 2.1).    
 
Natural Killer Cell Cytotoxicity. During gestation, at all days post-treatment (d 14, 21, and 28) 
PRO-sows had greater (p = 0.001) natural killer (NK) cell cytotoxicity than did CON-sows. 
However, at d 7 post-treatment (d 91 of gestation), CON-sows had greater NK cytotoxicity 
(Figure 2.2).  
 
Neutrophil Chemotaxis C5a and IL-8. Across gestation (p = 0.01), at d 7 and d 21 post-treatment 
(d 91 and d 105 of gestation), PRO-sows had greater C5a-induced neutrophil chemotaxis than 
did CON-sows. However, at d 14 post-treatment (d 98 of gestation) PRO-sows had lower 
chemotaxis than CON-sows. Among the CON-sows, neutrophil chemotaxis remained unchanged 
until d 28 post-treatment (d 112 of gestation), when the CON-sows had greater chemotaxis than 
did PRO-sows (Figure 2.3). During gestation, PRO-sows had greater IL-induced neutrophil 
chemotaxis at d 7 and d 28 post-treatment (d 91 and d 112 of gestation) than did CON-sows (p = 
0.02); while at d 14 and d 21 post-treatment (d 98 and d 105 of gestation), CON-sows had greater 
neutrophil chemotaxis than did PRO-sows (Figure 2.4).  
 
Interleukin-12. During gestation (p = 0.001), at d 7 and d 14 post-treatment (d 91 and 98 of 
gestation), PRO-sows had greater IL-12 than did CON-sows. However, by d 21 and d 28 post-
treatment (d 105 and d 112 of gestation), CON-sows had greater IL-12 than did PRO-sows 
(Figure 2.5).   
 
Experiment 2: Treatment x Day Effects during the Lactation Period 
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Plasma Cortisol. On d 31 post-treatment (24-hours post-farrowing) PRO-sows had lower plasma 
cortisol than did CON-sows (p = 0.001). At d 51 post-treatment (at weaning), plasma cortisol 
was lower regardless of treatment. PRO-sows had lower plasma cortisol (43.3 ± 6.9, ng/mL) than 
did the CON-sows (65.5 ± 8.5, ng/mL) at the end of lactation (Figure 2.6). 
 
Leukocyte Differentials. Leukocyte differentials were also affected by treatment during lactation 
(p ≤ 0.05). Once sows were moved to farrowing, PRO-sows had greater percentages of 
eosinophils and banded neutrophils (immature) on d 31 and d 51 post-treatment (24-hours post-
farrowing and at weaning) when compared to the CON-sows (Table 2.3). Segmented neutrophils 
and monocytes were greater in CON-sows on d 31 and d 51 post-treatment (24-hours post-
farrowing and at weaning) when compared to the PRO-sows (Table 2.3). PRO-sows had a 
greater percentage of lymphocytes on d 31 and d 51 post-treatment (24-hours post-farrowing and 
at weaning) compared to the CON-sows (Table 2.3).  
 
Natural Killer Cell Cytotoxicity. Once sows moved into farrowing (p = 0.02), on d 31 post-
treatment (24-hours post-farrowing) the PRO-sows had lower NK cytotoxicity than the CON-
sows, but by d 51 post-treatment (at weaning), PRO-sows had greater NK cytotoxicity than did 
CON-sows (Figure 2.7).  
 
Neutrophil Chemotaxis C5a. At d 31 post-treatment (24-hours post-farrowing) during lactation, 
CON-sows had greater chemotaxis than did PRO-sows (p = 0.001) (Figure 2.8).  
 
Interleukin-12. During lactation (p = 0.001), PRO-sows had greater IL-12 on d 31 and d 51 post-
treatment (24-hours post-farrowing and at weaning) when compared to the CON-sows (Figure 
2.9).  
 
Sow Body Weight 
Sow body weight (kg) on d 0 of treatment (d 84 of gestation), was similar between CON-sows 
(224.28 ± 6.11, kg) and PRO-sows (224.19 ± 6.46, kg); and similar on d 51 post-treatment (at 





Results of the sow study imply that feeding yeast-derived probiotics to sows during 
gestation and lactation may affect innate immune status of the sow and her biological responses 
to farrowing and weaning stresses, but have minimal effects on adaptive immunity with the 
exception of cytokine IL-12. During gestation, innate immune measures, especially neutrophil 
chemotaxis and natural killer (NK) cell cytotoxicity were enhanced after 3-weeks of feeding 
Saccharomyces cerevisiae boulardii (Scb), to gestating sows when compared to the control sows, 
but adaptive immune measures were unchanged. Plasma cortisol of the probiotic-treated sows 
was also lower than the control sows by day 115 of gestation. In response to farrowing and 
weaning stressors, the sows fed probiotics still had greater innate immune responsiveness and 
less activated acute stress responses (e.g., reduced cortisol), especially in response to weaning 
stress. These data imply that probiotics enhanced the innate immune responsiveness of the sows 
while reducing stress responsiveness to acute stressors (or in the short-term).  
 Interestingly, both neutrophil function and NK cell cytotoxicity were the primary innate 
immune parameters affected by feeding sows probiotics. Innate immune cells such as NK cells 
act as the first line of defense against viral pathogens (Friberg, 1996), and can be affected by 
changes in cortisol concentrations. As a subset of lymphocytes, NK cells are capable of 
controlling the immune response through the secretion of cytokines, with the primary effector 
function being the lysis of their targets. During gestation, PRO-sows had greater NK starting at 
14 days post-treatment and until sows were moved into farrowing crates. This may imply that 
feeding yeast probiotics to sows during gestation may have beneficial effects on innate immune 
response of a pregnant and/or lactating sow. Past research using the probiotic Lactobacillus casei 
strain Shirota (LcS) indicated that depletion of monocytes greatly reduced the effect of LcS on 
lymphocyte activation, cytokine production, and natural killer cell activity (Dong et al., 2010), 
whereas, we found an increase in monocytes and increase in NK cytotoxicity when sows were 
fed a yeast-probiotic (Scb). It can be speculated that NK cytotoxicity was enhanced among 
probiotic treated sows because of stimulatory effects of IL-12. Therefore, it is possible that 
continuing to feed probiotics during lactation may have also minimized the suppressive effects of 
weaning stress on NK cytotoxicity since these sows had greater NK cytotoxicity and less cortisol 
following weaning. For example, once sows moved on to the lactation period, PRO-sows had 
greater NK at d 51 post-treatment (at weaning), which may indicate that the probiotic treatment 
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benefited the PRO-sows not only during gestation but in response to weaning stress, with 
enhanced innate immune response and reduced stress responsiveness. Interestingly, there was no 
effect of either stressor on neutrophil chemotaxis even though during gestation probiotics 
affected this measure and at times neutrophils were increased in the periphery. 
As was stated previously, it is possible that the increase in IL-12 among probiotic treated 
sows may have also had a stimulatory effect on NK cytotoxicity. Even though adaptive immune 
measures were not affected by treatment, IL-12, a pro-inflammatory cytokine that activates T-
helper 1 cells which play a role in cell-mediated immunity (Trinchieri, 1995), was greater among 
the probiotic sows during gestation; but more importantly was stimulated in response to both 
farrowing and weaning stress. An in vitro study conducted by Shida et al. (2006), found that 
heat-killed Lactobacillus casei strain Shirota, (LcS) stimulated the IL-12 production. This study 
may suggest that the bacterial supplemented LcS probiotic modulates cytokine production, and 
that its effects appear to be strain-specific. The study by Shida et al. indicates that heat-killed 
bacterial probiotic preparations are capable of stimulating IL-12, which is also true of the yeast 
probiotic supplement, Scb, which was fed to PRO-sows in this study.   
 Elevated plasma cortisol is indicative of an activated stress axis (hypothalamic-pituitary-
adrenal (HPA) axis) or a need to mobilize energy due to low glucose concentrations. Greater 
concentrations of plasma cortisol may suppress the immune system, decrease bone 
formation/muscle wasting, and/or lead to proteolysis (breakdown of proteins) in the body 
(Herman et al., 2016). In this study, plasma cortisol was lower for the control sows until d 21 
post-treatment (d 105 of gestation) when the probiotic treated sows had lower plasma cortisol; 
these sows also had lower plasma cortisol in response to farrowing and weaning stresses. This 
may indicate that feeding yeast probiotics to sows may diminish the natural increase in plasma 
cortisol at the time of farrowing and weaning, while lowering baseline cortisol in pregnant sows 
(Anil et al., 2005; Tsuma et al., 1995). It should also be noted that despite the differential stress 
response between the probiotic and control sows, that on the day probiotic treatment was 
initiated (d 84 of gestation), the PRO-sows had significantly higher cortisol; however, it is 
plausible that this was due to control sows always being bled first and that early on in the study, 
the commotion and handling may affected the PRO-sows. Previous work by McGlone et al. 
(1993) found that pigs in adjacent pens were more affected by bleeding than pigs that were 
housed in the same pen. Regardless, these data imply that feeding sows probiotics during 
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gestation and lactation did affect plasma cortisol throughout gestation and lactation because 
PRO-sows did not have a greater stress response at weaning, even though the control sows were 
weaned and bled before the PRO-sows.    
Finally, feeding probiotics to sows also affects total white blood cell counts and 
differential leukocyte populations, especially neutrophils and monocytes during gestation.  
Neutrophils serve as the primary defense against bacterial infection and physiological stress 
(Black, 2011); while blood monocytes, once migrated into the tissue, serve as a secondary line of 
defense against infection and some inflammatory diseases. During gestation, mature neutrophils 
were increased during the first 3-weeks of feeding probiotics to sows during gestation, while 
during the last 3-weeks of gestation, monocytes were greater among probiotic treated sows. This 
may partly explain the lack of effects on adaptive immune measures in response to the probiotic 
treatment. Interestingly, greater percentages of immature neutrophils were prevalent among the 
control sows, often seen early in the response to infection and stress (Black, 2011), which may 
indicate that these sows were activating early immune defenses during the first 3-weeks of the 
gestational treatment.  
Previous research by Luke (1953) on the differential leukocyte count in the normal pig 
suggested that the overall increase in the total white cells may be associated with both the older 
age of the pig and the time of bleeding, thereby causing a variation in the total white blood cell 
count. This may explain why the CON and PRO sows had differing leukocyte differentials, in 
addition to higher plasma cortisol concentrations, in response to the beginning and end of the 
gestational treatment period. It implies that at the different days of treatment during the 
gestational period, the sows had to elicit specific immune responses to cope with potential 
baseline stressors, whether that occurred earlier or later in the gestation period. During the 
lactation period, at d 31 and d 51 post-treatment (24-hours post-farrowing and at weaning), PRO-
sows had greater percentages of eosinophils, banded neutrophils, and lymphocytes than CON-
sows did. Feeding sows the probiotic boluses may have aided the PRO-sows in having less 
responsiveness to farrowing and weaning stress, as can be seen by the greater percentages of the 
leukocyte differential. Segmented neutrophils and monocytes were not affected by the probiotic 
treatment during the lactation period. However PRO-sows did have greater effects during the 





During the sow study, it was hypothesized that feeding the yeast probiotic, 
Saccharomyces cerevisiae boulardii (Scb), may enhance both innate and adaptive immune 
measures of the gestating sow and affect both her immune response and stress-responsiveness to 
farrowing and weaning stressors. After three weeks of feeding probiotics, innate immune 
measures differed, with PRO-sows having more activated responses by d 105 of gestation 
compared with the control sows. Overall, feeding sows yeast probiotics during late gestation and 
through lactation resulted in greater innate immune status and reduced baseline plasma cortisol 
throughout gestation and lactation compared with the control sows. More specifically, at d 31 
post-treatment (24-h post-farrowing), the PRO-sows immune profile was different than that of 
the CON-sows, with greater cytokine IL-12, and leukocyte differential (percentage of 
eosinophils, banded neutrophils, and lymphocytes), as well as lower plasma cortisol in response 
to farrowing stress; while CON-sows had greater natural killer cell cytotoxicity, neutrophil 
chemotaxis C5a, and leukocyte differential (percentage of segmented neutrophils and 
monocytes) at 24-hours post-farrowing. Again at d 51 post-treatment (at weaning), PRO-sows 
had a greater overall immune profile, including natural killer cell cytotoxicity, cytokine IL-12, 
and leukocyte differential (percentage of eosinophils, banded neutrophils, and lymphocytes), as 
well as lower plasma cortisol in response to weaning stress. 
It is possible that feeding PRO-sows the yeast probiotic supplementation during the 
periods of gestation and lactation may positively impact innate immune responses and diminish 
the stress responsiveness to common stressors that are unavoidable during gestation and 
lactation. Greater responses to innate and adaptive measures, including having lower plasma 
cortisol during the lactation period, further expresses the interactive effects that may have aided 
the PRO-sows in having a decreased stress response to farrowing and weaning stressors. 
However, results varied between the CON and PRO sows in regards to the measures that were 
assessed. Feeding modified gestation diets to sows throughout pregnancy may reduce the 
incidence of infectious disease outbreaks, thereby optimizing health so that the need for sub-
therapeutic antibiotics declines. Therefore, the supplementation of the yeast probiotic boluses, 
Scb, during the period of gestation to weaning did have an impact on the immune status and 











(n = 9)  
Probiotic 
(n = 9) P-Value  
Plasma cortisol, ng/mL 
  
0.002* 
d7 31.3 ± 4.60 36.5 ± 7.90 
 d14 29.9 ± 4.50
a
 47.1 ± 6.30
b
 
 d21 45.0 ± 6.00
a
 36.9 ± 4.90
b
 
 d28 45.6 ± 5.00 47.5 ± 6.20 





d0 1.89 ± 0.05 2.00 ± 0.10 
 d7 2.17 ± 0.15 2.39 ± 0.22 
 d14 2.07 ± 0.11 2.45 ± 0.30 
 d21 2.01 ± 0.21 2.43 ± 0.36 






d0 3.83 ± 0.31 4.00 ± 0.42 
 d7 3.68 ± 0.36 3.33 ± 0.55 
 d14 3.47 ± 0.30 3.21 ± 0.27 
 d21 3.60 ± 0.37 3.44 ± 0.58 






d0 2.63 ± 0.30 2.34 ± 0.32 
 d7 2.78 ± 0.20
a
 3.62 ± 0.63
b
 
 d14 2.47 ± 0.21 2.37 ± 0.17 
 d21 2.36 ± 0.16 2.39 ± 0.37 
 d28 2.34 ± 0.20 1.83 ± 0.12 
 Eosinophils, % 
  
0.05*
d0 6.00 ± 0.33 6.11 ± 0.53  
d7 5.22 ± 1.19 5.56 ± 1.16 
 d14 5.44 ± 0.85
a
 3.89 ± 0.63
b
 
 d21 5.44 ± 1.04
a
 4.22 ± 0.61
b
 
 d28 3.89 ± 0.77
a
 5.44 ± 0.84
b
 
 Banded Neutrophils, % 
  
0.001* 
d7 3.00 ± 1.48 2.89 ± 1.49 
 d14 1.78 ± 0.76
a
 1.11 ± 0.48
b
 
 d21 3.44 ± 1.75 3.67 ± 2.13 
 d28 5.00 ± 2.51 4.22 ± 2.16 
 Segmented Neutrophils, % 
  
0.001*
d0 28.4 ± 3.88 31.1 ± 2.49  
d7 31.3 ± 1.78
a
 44.4 ± 5.12
b
 
 d14 32.8 ± 3.40
a
 41.4 ± 2.26
b
 
 d21 33.7 ± 2.58
a






Table 2.1 (Continued) 
 
d28 40.2 ± 3.40
a
 37.7 ± 2.77
b
 
 Lymphocytes, % 
  
0.001*
d7 56.0 ± 2.40
a
 44.4 ± 4.32
b
 
 d14 58.6 ± 4.24
a
 51.1 ± 2.44
b
 
 d21 53.4 ± 3.58
a
 48.7 ± 2.40
b
 
 d28 47.0 ± 2.59 46.3 ± 2.58 
 Monocytes, % 
  
0.001*
d0 2.89 ± 0.87 2.89 ± 0.59  
d7 3.33 ± 0.91 2.67 ± 0.7
b
 
 d14 1.33 ± 0.37
a
 2.44 ± 0.80
b
 
 d21 3.78 ± 0.96 4.33 ± 1.01 




Treatment x Day effect across gestation phase.
 
a,b 
Within a row, means without a common superscript differ (p ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
























(n = 9) 
Probiotic 
(n = 9) P-Value  
Phagocytosis, %   0.33 
d0 48.0 ± 4.66 49.2 ± 2.65  
d7 41.8 ± 4.13 43.8 ± 4.71  
d14 59.7 ± 4.01
c
 56.8 ± 3.48  
d21 59.1 ± 3.87
a
 54.5 ± 2.40
b
  
d28 49.1 ± 3.64
a
 63.1 ± 3.71
b
  
Natural killer cells (NK) 12.5, %   0.001* 
d7 8.04 ± 1.99 7.47 ± 1.56  
d14 29.3 ± 5.72
a
 52.1 ± 15.0
b
  
d21 30.5 ± 5.19
a
 48.6 ± 5.45
b
  
d28 43.3 ± 10.7
a
 59.1 ± 19.9
b
  
Chemotaxis C5a, Number of cells/4 fields   0.01* 
d7 7.75 ± 3.53
a
 14.1 ± 2.66
b
  
d14 7.92 ± 2.36
a
 5.08 ± 0.49
b
  
d21 5.42 ± 2.05
a
 9.33 ± 2.46
b
  
d28 9.75 ± 2.51 7.25 ± 1.89  
Chemotaxis IL-8, Number of cells/4 fields   0.02* 
d7 12.3 ± 3.38
a
 19.4 ± 3.93
b
  
d14 11.7 ± 1.75
a
 7.06 ± 1.34
b
  
d21 10.7 ± 2.11 9.33 ± 1.26  
d28 10.7 ± 2.73 13.1 ± 2.37  
Interleukin-12 (IL-12 Elisa), pg/mL   0.001* 
d7 174.40 ± 21.3 183.63 ± 21.8  
d14 185.21 ± 14.7 198.16 ± 20.5  







d28 180.44 ± 19.9 180.30 ± 12.0  
Concanavalin A Proliferation (ConA), 20.0    0.97 
d7 1.41 ± 0.26
a
 1.22 ± 0.08
b
  
d14 1.28 ± 0.19 0.92 ± 0.11  
d21 1.90 ± 0.34
a
 1.34 ± 0.07
b
  
d28 1.81 ± 0.22
a
 1.31 ± 0.10
b
  
Lipopolysaccharide Proliferation (LPS), 20.0   0.98 
d7 1.51 ± 0.33 1.83 ± 0.36  
d14 1.95 ± 0.49 1.24 ± 0.20  
d21 1.39 ± 0.20 1.28 ± 0.18  
d28 1.33 ± 0.09
a





Treatment x Day effect across gestation phase. 
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 




Table 2.2 (Continued) 
 
Days of gestation are equivalent to experimental days: d84 = d 0 of treatment (baseline, began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 




































(n = 9) 
Probiotic 
(n = 9) P-Value  
Plasma cortisol, ng/mL 
  
0.001* 
d28 45.6 ± 5.00 47.5 ± 6.20  
d31 79.5 ± 9.80
a
 64.6 ± 7.10
b
 
 d51 65.5 ± 8.50
a
 43.3 ± 6.90
b
 





d28 2.23 ± 0.22 2.28 ± 0.25  
d31 1.38 ± 0.16
c
 2.39 ± 0.42
d
 






d28 3.39 ± 0.30 3.79 ± 0.38  
d31 3.20 ± 0.63 4.28 ± 0.59 






d28 2.34 ± 0.20 1.83 ± 0.12  
d31 2.00 ± 0.35 2.24 ± 0.33 
 d51 2.25 ± 0.39 1.64 ± 0.15 
 Eosinophils, % 
  
0.001*
d31 3.11 ± 1.18 3.22 ± 1.05 
 d51 4.22 ± 0.62
a
 5.11 ± 1.06
b
 
 Banded Neutrophils, % 
  
0.001*
d28 5.00 ± 2.51 4.22 ± 2.16  
d31 12.7 ± 5.40 12.9 ± 5.66 
 d51 1.89 ± 0.87 2.33 ± 1.11 
 Segmented Neutrophils, % 
  
0.001*
d31 38.9 ± 7.06
a
 33.3 ± 3.80
b
 
 d51 45.4 ± 2.06
a
 37.7 ± 3.21
b
 
 Lymphocytes, % 
  
0.001*
d28 47.0 ± 3.10 46.3 ± 2.58  
d31 42.1 ± 3.35 45.6 ± 3.18 
 d51 45.7 ± 2.62 51.6 ± 4.63 
 Monocytes, % 
  
0.001*
d28 3.78 ± 0.72 4.22 ± 0.63  
d31 3.33 ± 0.76 3.00 ± 1.14 
 d51 3.11 ± 0.99
a





Treatment x Day effect across lactation phase. 
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 





Table 2.3 (Continued) 
 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline), d 115 = d 31 of treatment (24-hours post-farrowing), and d 135 

































(n = 9) 
Probiotic 




d31 60.1 ± 5.45 60.4 ± 6.48 
 d51 54.9 ± 3.89 54.0 ± 5.28 
 Natural killer cells (NK) 12.5, % 
  
0.02*
d31 30.8 ± 3.32
a
 19.8 ± 1.14
b
 
 d51 67.8 ± 20.3 78.9 ± 15.0 
 Chemotaxis C5a, Number of cells/4 fields   0.001* 
d28 9.75 ± 2.51 7.25 ± 1.89  
d31 32.8 ± 11.0
a
 22.4 ± 3.04
b
  
Interleukin-12 (IL-12 Elisa), pg/mL   0.001* 
d28 180.44 ± 19.9 180.30 ± 12.0  
d31 147.82 ± 17.2 149.96 ± 9.73  
d51 201.67 ± 18.2 219.92 ± 19.3  
Concanavalin A Proliferation (ConA), 20.0 
  
0.88 
d28 1.81 ± 0.22 1.31 ± 0.10  
d31 1.83 ± 0.22 2.00 ± 0.30 
 d51 1.48 ± 0.13 2.08 ± 0.26 
 Lipopolysaccharide Proliferation (LPS), 20.0 
  
0.86
d28 1.33 ± 0.09
a
 1.13 ± 0.02
b
  
d31 1.16 ± 0.06 1.34 ± 0.09 
 d51 1.17 ± 0.12 1.23 ± 0.20 
  
* 
Treatment x Day effect across lactation phase. 
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline), d 115 = d 31 of treatment (24-hours post-farrowing), and d 135 













Figure 2.1 Treatment x day effect
1
 on plasma cortisol
2









 Least squares means ± SE; Treatment x day effect across gestation phase; p = 0.002
 
2 
Plasma cortisol, ng/mL 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
treatment; d 105 = d 21 of treatment; d 112 = d 28 of treatment (sows moved into farrowing 
crates).  








































Day of Treatment 
Treatment x day effect1 on plasma cortisol2 of pregnant sows3 





Figure 2.2 Treatment x day effect
1
 on natural killer cell cytotoxicity
2







 Least squares means ± SE; Treatment x day effect across gestation phase; p = 0.001
 
2 
Cytotoxicity %, 12.5:1 effector to target 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
treatment; d 105 = d 21 of treatment; d 112 = d 28 of treatment (sows moved into farrowing 
crates).  














































Day of Treatment 
Treatment x day effect1 on natural killer cell cytotoxicity2 of 





Figure 2.3 Treatment x day effect
1
 on neutrophil chemotaxis (C5a)
2









 Least squares means ± SE; Treatment x day effect across gestation phase; p = 0.01
 
2 
Neutrophil chemotaxis (C5a), number of cells/4 fields 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
treatment; d 105 = d 21 of treatment; d 112 = d 28 of treatment (sows moved into farrowing 
crates).  






























































Day of Treatment 
Treatment x day effect1 on neutrophil chemotaxis (C5a)2 of pregnant 





Figure 2.4 Treatment x day effect
1
 on neutrophil chemotaxis (IL-8)
2








 Least squares means ± SE; Treatment x day effect across gestation phase; p = 0.02
 
2 
Neutrophil chemotaxis (IL-8), number of cells/4 fields 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
treatment; d 105 = d 21 of treatment; d 112 = d 28 of treatment (sows moved into farrowing 
crates).  



























































Day of Treatment 
Treatment x day effect1 on neutrophil chemotaxis (IL-8)2 of 





Figure 2.5 Treatment x day effect
1
 on cytokine Interleukin-12
2










 Least squares means ± SE; Treatment x day effect across gestation phase; p = 0.001
 
2 
Interleukin-12 (IL-12), pg/mL 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of gestation are equivalent to experimental days: d 84 = d 0 of treatment (baseline; began 
feeding placebo or yeast probiotic boluses to sows); d 91 = d 7 of treatment; d 98 = d 14 of 
treatment; d 105 = d 21 of treatment; d 112 = d 28 of treatment (sows moved into farrowing 
crates).  











































Day of Treatment 
Treatment x day effect1 on cytokine Interleukin-122 of pregnant 





Figure 2.6 Treatment x day effect
1










 Least squares means ± SE; Treatment x day effect across lactation phase; p = 0.001
 
2 
Plasma cortisol, ng/mL 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline), d 115 = d 31 of treatment (24-hours post-farrowing), and d 135 
= d 51 of treatment (piglets weaned from sows).  
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Figure 2.7 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across lactation phase; p = 0.02
 
2 
Cytotoxicity %, 12.5:1 effector to target 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline), d 115 = d 31 of treatment (24-hours post-farrowing), and d 135 
= d 51 of treatment (piglets weaned from sows).  















































Day of Treatment 
Treatment x day effect1 on natural killer cell cytotoxicity2 of sows3 





Figure 2.8 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across lactation phase; p = 0.001
 
2 
Neutrophil chemotaxis (C5a), number of cells/4 fields 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline); d 115 = d 31 of treatment (24-hours post-farrowing). 




























































Day of Treatment 
Treatment x day effect1 on neutrophil chemotaxis (C5a) 2 of sows3 





Figure 2.9 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across lactation phase; p = 0.001
 
2 
Interleukin-12 (IL-12), pg/mL 
3 
Control (CON) vs. Probiotic (PRO) sows 
4 
Days of lactation are equivalent to experimental days: d 112 = d 28 of treatment (sows moved 
into farrowing crates; baseline), d 115 = d 31 of treatment (24-hours post-farrowing), and d 135 
= d 51 of treatment (piglets weaned from sows).  











































Day of Treatment 
Treatment x day effect1 on cytokine Interleukin-122 of sows3 
















Least squares means ± SE
 
2 
Control vs. Probiotic sows 
3 
Body Weight, kg 
4 
Days of gestation and lactation are equivalent to experimental days: d 84 = d 0 of treatment 
(baseline; began feeding placebo or yeast probiotic boluses to sows); and d 135 = d 51 of 
treatment (piglets weaned from sows). 



































Body Weight at Beginning and End of Trial 
Effect of treatment1 on sow2 body weight3 during late 




CHAPTER 3. THE EFFECT OF MATERNAL-FETAL PROGRAMMING BY 
TRANSFERRING THE IMMUNE STATUS AND STRESS RESPONSIVENESS OF THE 




 The establishment of microbiota in the neonate is dependent on the inter-relationship 
between the environment and maternal factors (i.e., nutrition). Piglets are born with a sterile, 
non-colonized gastrointestinal tract without a functional immune system (Romano-Keeler and 
Weitkamp, 2014). Early colonization events affected by the sow may have profound and long-
term effects on the development of mucosal immunity, gut architecture, and microbiota 
composition of the neonate. Stress during late gestation may impair the development and 
reactivity of the sow’s offspring which impacts disease susceptibility and mortality (Tuchscherer 
et al., 2002). It has been further speculated that other impingements (stressors) play a crucial role 
in the ability of the host to utilize innate and adaptive immune responses that may otherwise 
compromise animal health and lead to disease outcome, or resolve the challenges and achieve 
homeostasis. A study conducted by Clapperton et al. (2009) emphasized the need for genetic 
biomarkers capable of predicting offspring’s resistance towards infectious diseases. Regardless 
of health status, the study concluded that innate and adaptive immune traits had strong genetic 
and phenotypic correlations between average growth rate and performance. In pig production, 
husbandry practices can cause suppression and/or enhancement of the immune system. 
Unavoidable production stressors within animal production systems tend to exacerbate the 
disease process, often by compromising the immune system of an animal (Salak-Johnson and 
McGlone, 2007). Therefore, the use of innate and adaptive immune biomarkers may serve as 
metrics for selecting offspring with increased resistance to infectious diseases or with an 
increased ability to maintain high performance levels during periods of unavoidable stress.  
It is hypothesized that sows fed the supplemented yeast probiotic diet, Saccharomyces 
cerevisiae boulardii (Scb), during the periods of late gestation until weaning could potentially 
transfer beneficial immune and stress responsiveness to her offspring. Piglets born to the 
probiotic-treated sows (PRO-piglets) may have an enhanced responsiveness to farrowing and 
processing stressors when compared to the piglets born to the control sows (CON-piglets). More 
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specifically, piglets from PRO-sows will have a greater immune status during the period of 
suckling (d 0 – d 21 of age) and diminished stress responsiveness (e.g., lower cortisol). During 
the period of weaning, piglets from PRO-sows will have a greater responsiveness to both the 
short- and long-term effects of acute stress compared to the CON-piglets. Therefore, the 
objectives of this study were to assess the effects of feeding yeast probiotics, Scb, to sows during 
late gestation through lactation on the immune status of her piglets from birth till weaning; and 
stress responsiveness of her piglets in response to farrowing and processing stressors, and to 
assess the effects on the stress responsiveness of piglets to weaning stress in short- and long-term 
periods (d 21 – d 35 of age).  
 
MATERIALS AND METHODS 
Animals and Experimental Design 
 All procedures were approved by the University of Illinois at Urbana-Champaign and the 
Institutional Animal Care and Use Committee (IACUC). A total of eighty-four female piglets, 
born to sows derived of the Genetiporc maternal line were used in this study. The piglets were 
selected from 18 litters born to sows fed either probiotics (PRO; n = 9) or placebo (CON; n = 9) 
during gestation and lactation. All piglets were housed at the University of Illinois Swine 
Research Center in Urbana-Champaign. Piglets remained with their dams until d 21 of age. At 
weaning, piglets were moved to the nursery as littermates and penned together. In the nursery, 
piglets were fed ad libitum, a standard nursery diet, and each nursery pen contained one nipple 
waterer. All piglets were kept on a 10 h light: 14 h dark schedule, in which lights were on at 
0700 h and off at 1700 h.  
Piglets from dams that were fed either probiotics (PRO; n = 42) or placebo (CON; n = 
42) were randomly selected from each treatment and assessed for immune and endocrine metrics 
at twoexperimental periods. Each experimental day is equivalent to day-of-age of piglet.  At 
farrowing (d 0 of age) and until weaning (d 21 of age), piglets were housed with their dams and 
blood samples were taken at d 0 (day of birth), d 1A (pre-processing), d 1B (post-processing), d 
7, d 14, and d 21 (at weaning) of age (Phase 1). Phase 2 blood samples were taken at d 21 (at 
weaning), d 22 (24-hours post-weaning), d 28 (7 days post-weaning), and d 35 (14 days post-
weaning) of age. Fixed-effects parameters of treatment (control or probiotic-treated sows) and 
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day of age for piglets were used for this study; therefore, piglets were not fed a probiotic 
treatment during this research. 
 
Blood Sample Collection and Leukocyte Differentials 
Sows were observed continuously until they farrowed. A birth, piglets were dried off and 
1 mL of blood was collected via jugular venipuncture with vacutainers containing sodium 
heparin or EDTA at (d 0) and 5-10 mL of blood was collected at the remaining time points. The 
procedure lasted <2 mins. At birth, blood samples and body weights were taken prior to 
suckling. Heparin-treated whole blood was used to determine total white blood cell (WBC) 
counts and leukocyte differential counts (DIFF). Total WBC counts were made electronically 
using a Coulter Z1 particle counter (Beckman Coulter, Miami, FL). Ten microliters (10 μl) of 
whole blood was added to 10 mL of Beckman Coulter, Isoflow®, red blood cells were lysed with 
Beckman Coulter lytic reagent, ZAP-OGLOBIN® and then samples were placed in the counting 
chamber to determine total BBC count. To determine DIFF percentages, whole blood smears 
were made, fixed in methanol, and then stained with Hema-3 staining system (Fisher Scientific, 
Houston, TX). Slides were viewed under a light microscope, and 100 cells per slide were 
visually counted.  
 
Cell Isolation and Plasma Analysis   
Whole blood was collected and centrifuged at 700 × g for 30 min at 4℃. Plasma was 
aspirated and transferred to Eppendorf tubes and stored at -80°C until further analysis. Whole 
blood was diluted with Roswell Park Memorial Institute (RPMI; Gibco, Carlsbad, CA) medium, 
layered over Histopaque-1077 (density = 1.077g/mL; Sigma) and -1119 (density = 1.119 g/mL; 
Sigma), and centrifuged at 700 x g for 30 min at 25°C. Lymphocytes were removed from the top 
of the second layer and neutrophils from the top of the third layer. Red blood cells were lysed 
from the neutrophil fraction, which was then washed in RPMI and counted. Cell concentrations 
were adjusted with RPMI based on the immune assay requirements. Whole blood was diluted 
using Roswell Park Memorial Institute (RPMI) media.  
Plasma cortisol and IL-12 were analyzed following manufacturer’s protocols. 
Commercial radioimmunoassay validated for porcine cortisol was measured. Plasma samples 
from heparin-treated whole blood were assayed for CORT using a Coat-A-Count cortisol kit, 
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following the manufacturer’s protocol (Diagnostic Products Corp., Los Angeles, CA). Briefly, in 
duplicate, 25 µL of sample or standard were added to antibody-coated tubes. Radiolabeled (I125) 
CORT was added to tubes and incubated for 45 min at 37°C in a water bath. The liquid phase 
was decanted and radioactivity counted with a gamma counter. A standard curve based on 0, 10, 
50, 100, 200, and 500 µg/mL was used. Intra- and inter-assay CV were 7.0 and 16.5%, 
respectively. Minimal detectable concentration of CORT using this assay was approximately 2 
ng/mL. Porcine IL-12/IL-23 Quantikine kit was used to measure IL-12 in plasma samples (R & 
D Systems, Minneapolis, MN). Minimal detectable concentration of IL-12/IL-23 using this kit 
was on average 9.0 pg/mL.  
 
Immune Assays 
 Neutrophil phagocytosis was measured using a flow cytometry-based assay previously 
described by Heinzelmann et al. (1999), with minor modifications described by Niekamp et al. 
(2006). Briefly, fluorescent beads were pre-incubated for 30 min with non-heat-inactivated 
porcine serum before adding the fluorescent beads to the samples at a 10:1 (beads: neutrophils) 
ratio. Cells and beads were incubated together for 45 min at room temperature. The percentage 
of engulfment of beads by neutrophils was evaluated using flow cytometer.  
 Using Promega CellTiter®, a colorimetric method for determining the number of viable 
cells in proliferation, cytotoxicity, and chemo sensitivity assays, with slight modifications 
described by Sutherland et al. (2005), a mitogen-induced lymphocyte proliferation assay was 
performed. First, lymphocytes from the sow were used at a concentration of 5 x 10
6 
cells/mL, 
and placed in a sterile 96-well flat-bottom plate (sample run in triplicate per sow). Concanavalin 
A (ConA) and lipopolysaccharide (LPS), both acquired from Sigma Aldrich, were used as 
mitogens in order to stimulate T and B cells. ConA and LPS were both used at measurements of 
0.2, 2.0, and 20 μg/mL. Plates were incubated for sixty-eight hours at a temperature of 37℃ in a 
5% CO2 humidified incubator. Next, 15μL of Promega Dye was added to each well, and the 
plates were incubated for an additional four hours. Promega Stop solution (100 μL) was added to 
each well, and the plates were incubated overnight at a temperature of 37℃. Finally, using BIO-
TEK Instruments® microplate reader at a wavelength of 550 nm with reference wavelength 690 




Optical Density (550/690 nm) stimulated cells 
PI = 
Optical Density (550/690 nm) non-stimulated cells 
 
 A nonradioactive cytotoxicity detection kit acquired from Roche Diagnostics®, also 
described previously by Sutherland et al. (2005), was used to measure natural killer (NK) cell 
cytotoxicity. First, sow lymphocytes were used as effector cells, while K-562 chronic human 
myelogenous leukemia cells (American Tissue Type Culture Collection, Manassas, VA) were 
used as target cells. Lymphocytes were adjusted to 1 x 10
7 
cells/mL, and K-562 cells were 
adjusted to a constant 10,000 cells per wall. Second, samples were run in triplicate at effector to 
target-cell ratios of NK 12.5:1, 25:1, 50:1, and 100:1. Third, plates were read using BIO-TEK 
Instruments® microplate reader at a wavelength of 490 nm with reference wavelength 690 nm, 
after an eighteen hour incubation period. Finally, percent cytotoxicity was calculated as 
previously described by Lumpkin and McGlone (1992). An assay was thus considered valid as 
long as the maximum release, divided by spontaneous release, was ≤ 20%.  
 
Piglet Body Weight 
Piglet body weights were recorded at various time points throughout the study. During 
the suckling period (phase 1), piglet body weights were recorded on days 1A (pre-process), 1B 
(post-process), 7, 14, and 21 (at weaning) of age. During the weaning period (phase 2), body 
weights were recorded on d 21 (at weaning), d 22 (24-h post-weaning), d 28 (7 d post-weaning), 
and d 35 (14 d post-weaning) of age.  
 
Statistical Analysis 
 Data were analyzed using PROC MIXED with repeated measures SAS (SAS Inst. Inc., 
Cary, NC), mixed linear models contained both fixed- and random-effects parameters. Data were 
analyzed for the suckling phase, including days 0, 1A, 1B, 7, 14, and 21 of age. Data were 
analyzed for the weaning phase, including d 21 (at weaning), d 22 (24-h post-weaning), d 28 (7 d 
post-weaning), and d 35 (14 d post-weaning) of age. The model included fixed-effects 
parameters of treatment, control or probiotic, as well as day of age for piglets. Significance of 





Experiment 1: Treatment x Day Effects during the Suckling Period 
Plasma Cortisol. Plasma cortisol (p = 0.001) at farrowing (d 0 of age) for CON-piglets (204.54 ± 
10.8, ng/mL) was greater when compared to the PRO-piglets (111.17 ± 11.7, ng/mL). At d 1A 
(pre-processing of piglets), d 1B (post-processing of piglets), d 14, and d 21 (at weaning) of age, 
PRO-piglets had greater plasma cortisol than did CON-piglets. At d 7 of age PRO-piglets had 
lower plasma cortisol than did CON-piglets (Figure 3.1).  
 
Total WBC and Neutrophil and Lymphocyte Counts. Total WBC counts were greater (p = 0.03) 
in CON-piglets at d 0 (birth) and d 7 of age when compared to the PRO-piglets. At d 1A of age 
(pre-process) and 1B (post-process) PRO-piglets had greater total WBC counts when compared 
to the CON-piglets (Figure 3.2). At d 14 of age, total WBC counts were similar between 
treatment groups, but at d 21 of age, PRO-piglets had greater total WBC counts when compared 
to the CON-piglets (Figure 3.2). At d 7 of age, CON-piglets had a greater (p = 0.04) neutrophil 
counts than did PRO-piglets. At d 14 and d 21 (at weaning) of age, PRO-piglets had greater 
neutrophil counts than did CON-piglets (Figure 3.3). PRO-piglets had greater (p = 0.001) 
lymphocyte counts on d 7 and d 14 of age when compared to the CON-piglets. At weaning (d 21 
of age), the CON-piglets had greater lymphocyte counts than did PRO-piglets (Figure 3.4).  
 
Leukocyte Differentials. At processing, At d 0, d 1A (pre-process), and d 1B (post-process) of 
age PRO-piglets had greater (p = 0.001) percentage of segmented neutrophils than did CON-
piglets, but at d 7 and 14 of age, CON-piglets had greater percentage segmented neutrophils 
(Figure 3.5). By d 21 (at weaning) of age, both CON- and PRO-piglets had similar percentage of 
segmented neutrophils. The percentage of lymphocytes (p = 0.001) were greater at d 0, d 1A 
(pre-process), and d 1B (post-process) of age for CON-piglets when compared to PRO-piglets. 
However, PRO-piglets had a greater percentage of lymphocytes at d 7 and d 14 of age than did 
CON-piglets. But, by d 21 (at weaning) of age, both CON and PRO piglets had similar 
percentage of segmented neutrophils (Figure 3.6).  
 
Neutrophil Phagocytosis and Natural Killer Cell Cytotoxicity. Neutrophil phagocytosis was 
similar at d 7 of age for both CON and PRO piglets, but at d 14 of age, the CON-piglets had 
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greater (p = 0.011) phagocytosis than did PRO-piglets. But, by d 21 (at weaning) of age, PRO-
piglets had greater neutrophil phagocytosis when compared to the CON-piglets (Figure 3.7). 
Natural killer cell cytotoxicity at d 7 and d 14 of age (was greater (p = 0.03), in PRO- piglets 
when compared to CON-piglets (Figure 3.8). By d 21 (at weaning) of age, both CON and PRO 
piglets had similar NK. All other measures of innate immunity were not different.  
 
Interleukin-12. At d 0 and d 7 of age, CON-piglets had greater (p = 0.001) IL-12 than did PRO-
piglets. At d 1A (pre-process), d 1B (post-process), d 14, and d 21 (at weaning) of age, PRO-
piglets had greater plasma IL-12 than did CON-piglets (Figure 3.9).  
 
Lipopolysaccharides. At d 7 and 21 (at weaning) of age, LPS-induced lymphocyte proliferation 
index was greater (p < 0.05) in PRO-piglets when compared to CON piglets. At d 14 of age, 
CON-piglets had greater LPS-induced proliferation than did PRO-piglets (Figure 3.10). All other 
measures of adaptive immunity were not different.  
 
Experiment 2: Treatment x Day Effects during the Weaning Period 
Plasma cortisol. At weaning (d 21 of age) and 7 d post-weaning (d 28 of age), PRO-piglets had 
greater (p = 0.026) plasma cortisol than did CON-piglets. But, 14 d post-weaning (d 35 of age) 
PRO-piglets had a lower (0.03) plasma cortisol than did CON-piglets (Figure 3.11).  
 
Total WBC and Neutrophil and Lymphocyte Counts. No treatment x day interaction occurred for 
total WBC during weaning. At weaning, PRO-piglets had greater neutrophil counts at d 21 of 
age than did CON-piglets. At days 22, 28, and 35 of age, the CON-piglets had greater (p = 0.03) 
neutrophil counts when compared to PRO-piglets (Figure 3.12). CON-piglets had greater (p = 
0.02) lymphocyte counts on days d 21, 22, and 35 of age when compared to the PRO-piglets. 
But, 7 d post-weaning (d 28 of age), both CON and PRO piglets had similar lymphocyte counts 
(Figure 3.13).  
 
Leukocyte Differentials. Only at d 28 and 35 of age did percentage of segmented neutrophils 
differ (p ≤ 0.05) between CON- and PRO-piglets; with the CON-piglets having greater 
percentage of segmented neutrophils than the PRO-piglets (Figure 3.14). Only at d 35 of age, did 
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percentage of lymphocytes differ, with PRO-piglets having greater percentages than did CON-
piglets (Figure 3.15).  
 
Neutrophil Phagocytosis and Natural Killer Cell Cytotoxicity. At days 21, 28, and 35 of age, the 
PRO-piglets had greater (p = 0.012) neutrophil phagocytosis than did CON-piglets. At d 22 of 
age (24-h post-weaning), the CON-piglets had greater phagocytosis than did PRO-piglets (Figure 
3.16). Natural killer cell cytotoxicity was similar for both CON and PRO piglets on d 21 (at 
weaning) of age, but at days 22, 28, and 35 of age, CON-piglets had greater (p = 0.014), NK 
cytotoxicity than did PRO-piglets (Figure 3.17). All other measures of innate immunity were not 
different. 
 
Interleukin-12. At days 21, 22, and 35 of age, PRO- piglets had greater (p = 0.001) plasma IL-12 
than did CON -piglets. However, at d 28 (24-hours post-weaning) of age, CON piglets had 
greater IL-12 than did PRO-piglets (Figure 3.18). All other measures of adaptive immunity were 
not different.  
 
Piglet Body Weight 
Piglet body weight (kg), for CON and PRO piglets was recorded during the suckling and 
weaning periods. During suckling, days 1B (post-process), 7, 14, and 21 (at weaning) of age 
were reported. During the weaning period, days 21 (at weaning), 22, 28, and 35 of age were 
reported. Throughout the study, piglet body weight was similar between the CON and PRO 
piglets. Therefore, for each time point taken, piglet body weight was similar, regardless of 
whether they were offspring from dams fed the control (CON-sows) or probiotic (PRO-sows) 
treatments (Figure 3.19). 
 
DISCUSSION 
Results of the piglet study imply that feeding yeast-derived probiotics to sows during 
gestation and lactation may affect innate immune status of the dams’ offspring, as well as the 
piglets’ biological responses to farrowing, processing, and weaning stresses; but have minimal 
effect on adaptive immunity with the exception of cytokine IL-12 and LPS-induced mitogen 
proliferation. During farrowing stress, innate immune measures, especially the subset of 
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neutrophils in the leukocyte differential was enhanced at birth (d 0 of age) in piglets from dams 
that were fed the probiotic treatment (PRO-piglets) when compared to the control piglets (CON-
piglets). Also, plasma cortisol was lower in the PRO-piglets when compared to the CON-piglets 
at birth. During processing stress, innate and adaptive immune measures, especially total WBC 
count, leukocyte differential (subset of neutrophils), and cytokine IL-12 were enhanced at d 1A 
and d 1B of age (pre- and post-processing) in PRO-piglets when compared to CON-piglets. The 
immune effects that occurred during the first 24-hours of age for the PRO-piglets are most likely 
due to the treatment that the probiotic-treated sows were given during late gestation. In addition, 
the immune effects that the PRO-piglets experienced from d 0 (birth) to d 7 of age are likely due 
to the PRO-sows’ treatment during both gestation and lactation. Finally, during weaning stress, 
innate and adaptive immune measures, especially total WBC count, neutrophil phagocytosis, 
cytokine IL-12, and LPS-induced mitogen proliferation were enhanced at d 21 of age (at 
weaning) in PRO-piglets when compared to the CON-piglets’ response to acute weaning stress. 
These data imply that probiotics may enhance the innate and adaptive immune response of 
offspring from probiotic-treated dams, while reducing the stress responsiveness of these piglets 
to multiple stressors.  
Contrasting to the results that were found for PRO-sows, PRO-piglets had an overall 
lower response to the leukocyte differential during the suckling and weaning periods. It has been 
suggested in previous studies that immune parameters (including: lymphocytes, leukocyte, and 
neutrophils) increase in supplementation of synbiotic when compared to the single 
administration of lactobacillus in weaned pigs, as was previously described by Rivera et al. 
(2002). However, results of this study did not find an overall apparent increase in total WBC 
count, neutrophil and lymphocyte counts, or leukocyte differential for the PRO-piglets. In the 
piglet study, total WBC counts only had an effect during the suckling period. PRO-piglets had 
greater WBC counts on d 1A and d 1B of age (pre- and post-process), indicating a greater 
responsiveness to processing stress when compared to the CON-piglets. By d 14 of age, both 
CON and PRO piglets had similar WBC counts. However, PRO-piglets had a greater WBC 
count on d 21 of age (at weaning), which may suggest that PRO-piglets had a greater 
responsiveness to weaning stress than did CON-piglets.  
Treatment x day effects were reported for subsets of segmented neutrophils and 
lymphocytes in the leukocyte differential, as well as in total neutrophil and lymphocyte counts, 
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during the periods of suckling and weaning. Segmented neutrophils, which are the most common 
of the white blood cells (WBC) and serve as the primary defense against bacterial infection and 
physiological stress (Black, 2011), were greater in PRO-piglets on d 0 (at birth), d 1A, and d 1B 
of age (pre- and post-process) during the suckling period when compared to CON-piglets. 
Moreover, PRO-piglets had greater total neutrophil counts on d 14 of age during the suckling 
period, as well as on d 21 of age (at weaning). This may indicate that the probiotic treatment 
benefited the PRO-piglets in responsiveness to farrowing, processing, and weaning stressors. The 
subset of lymphocytes in the leukocyte differential, as well as in the total lymphocyte count, was 
greater at the end of the suckling period (d 7 and d 14 of age) for PRO-piglets when compared to 
CON-piglets. In addition, PRO-piglets had greater percentage of lymphocytes on d 22 of the 
weaning period (24-hours post-weaning). Lymphocyte results may suggest that the probiotic 
treatment may have positively affected the PRO-piglets during the second half of the suckling 
period, as well as at 24-hours post-weaning.  
Research conducted by Kawakami et al. (2010) found that calves administered the 
probiotic, Lactobacillus plantarum, reported no leukocyte increases in the peripheral blood of the 
treated calves during the experimental treatment, which is not true of the results reported for the 
PRO-piglets. The author speculates that it is more likely that the innate aspect of the immune 
system is enhanced for challenges. It may initially be perceived that PRO-piglets have a greater 
stress response since increased neutrophils are often a sign of acute stress if the N:L ratio is 
higher; however, this may not be the case in conjunction with total white blood cells, indicating 
that this may be a positive effect and that the piglets aren’t exhibiting stress. Results of this study 
on Scb reported different results from past studies on the use of prebiotic and probiotic 
supplemented diets in piglets. Shim (2005) reported that hematological traits (including: WBC, 
neutrophil, and lymphocyte counts) were unaffected by prebiotic, multi-strain probiotic, and 
synbiotic in weaned pigs. Similarly, the effects of probiotic and prebiotic on the immune system 
status of newborn female calves indicated no significant difference in WBC count, neutrophil, 
lymphocyte, and monocyte concentration at plasma concentration at any collection period taken, 
as previously conducted by Roodposhti and Dabiri (2012).  
Interestingly, neutrophil phagocytosis and natural killer (NK) cell cytotoxicity were the 
primary innate immune parameters affected by feeding the offspring’s dams probiotics. Innate 
immune cells such as NK cells act as the first line of defense against pathogens (Friberg, 1996), 
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and can be affected by elevated cortisol. As a subset of lymphocytes, NK cells are capable of 
controlling the immune response through the secretion of cytokines, with the primary effector 
function being the lysis of their targets. In a study conducted by Niekamp et al. (2007), it was 
hypothesized that weaning age has a marketed effect on the immune status of the piglet. Results 
showed that piglets weaned at 14-days-old had lower NK cell cytotoxicity when compared to 
piglets weaned between 21-28 days old. Older piglets were thus able to generate stronger 
immune responses when stimulated by environmental antigens during weaning. The authors 
concluded that piglets with high immune system activation thus had a decreased weight gain and 
food intake. PRO-piglets in this study showed dissimilar results to those reported by Niekamp et 
al., seeing as NK was higher in both CON and PRO piglets at d 35 of age, when compared to d 
21 of age (at weaning). PRO-piglets only had greater NK cytotoxicity when compared to the 
CON-piglets on d 7 of age during the suckling period. NK results suggest that the probiotic 
treatment did not benefit PRO-piglets during this study overall. These results were very different 
to the results that were found for the PRO-sows that were directly fed the probiotic treatment.  
Early weaning of piglets can cause oxidative stress by producing increased levels of 
reactive oxygen species, as was previously described by Dowarah and Agarwal (2016). The 
physiological concentration of reactive oxygen species is of particular importance when 
considering normal cell function, energy production, phagocytosis, and intercellular signaling 
regulation. The function of phagocytosis is to ingest and destroy pathogens. This process, by 
which a cell engulfs a solid particle in order to form a phagosome, results in the removal of 
pathogens and cell debris from the body. On d 21 (at weaning) of age, PRO-piglets had greater 
phagocytosis measures when compared to the CON-piglets. PRO piglets also had greater 
phagocytosis at days 28 and 35 of age. Phagocytosis results suggest that the probiotic treatment 
may have positively affected the PRO-piglets at weaning, as well as during the long-term 
assessment of the post-weaning period. Supporting research on the effect on the immune status 
of germ-free piglets of probiotics potentiated with polyunsaturated fatty acids was reported by 
Kastel et al. (2007). Results of this study at d 28 of age (7 d post-treatment) showed significant 
differences in the phagocytic activity of neutrophils and phagocytic activity of potentially 
phagocytizing cells of piglets, similar to the results seen for PRO-piglets in the weaning period.  
Maternal stress and its impact on the offspring can occur both prenatal and postnatal, 
thereby affecting early life stressors. Prenatal stresses are those changes that occur in utero, 
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which also include functions of the HPA axis including basal activity and stress responsiveness.  
Moreover, postnatal stress can have excitatory or inhibitory effects on an animal which can alter 
cognitive ability and anxiety (Nuriel-Ohayon, 2016; Wu et al., 1998). At birth (d 0) and d 7 of 
age, plasma cortisol secretion was lower for the PRO-piglets when compared to the CON-piglets. 
Long-term effects of weaning found that at d 35 of age (14 d post-weaning), PRO-piglets had 
lower plasma cortisol levels as well. Plasma cortisol results suggest that the probiotic treatment 
did not substantially benefit PRO-piglets, except at birth (in response to farrowing stress), during 
the middle of the suckling period, and in response to long-term stress responsiveness. A study 
conducted by Wang et al. (2013) found that supplementing the probiotic agent lactic acid 
bacteria, Lactobacillus reuteri (noted as being one of the few endogenous Lactobacillus species 
that are found within the gastrointestinal tracts of the pig), thus alleviated oxidative stress and 
enhanced the performance of weanling pigs. This may be similar to results seen in this study, as 
PRO-piglets had lower plasma cortisol in response to farrowing stress, as well as in response to 
long-term weaning stress (d 35 of age). Another study by Heinrich et al. (2002) found that even 
though differences were not significant among control and treated weaned pigs, that plasma 
concentration tended to be greater in synbiotic and probiotic treated animals overall, which was 
similarly seen in the PRO-piglets of this study in general (across both periods of treatment). 
Again, plasma levels were reportedly highest after birth due to the passive transfer of colostrum 
antibodies, which is then reduced until the animal is capable to producing its own antibodies 
(Riddell et al., 2010). This was true of both the CON and PRO piglets at d 0 of age (birth); 
however, PRO-piglets did have a lower response than did CON-piglets.  
 Interestingly, both cytokine IL-12 and LPS-induced mitogen proliferation were the 
primary adaptive immune parameters affected by feeding the offspring’s dams the probiotic 
treatment. Interleukin-12, a pro-inflammatory response which thereby induces an immune 
response, plays a key role in the induction of Th1 immune responses (Trinchieri, 1995). Deng et 
al. (2007) reported that dietary supplementation with polysaccharides may increase interleukin, 
since polysaccharides may enhance the cell-mediated immune response as well as the humoral 
immunity in early-weaned piglets. At d 1A, d 1B, and d 14 of age during the suckling period, 
PRO-piglets had greater IL-12 than did CON-piglets. Once piglets moved on to the weaning 
period, PRO-piglets had greater IL-12 on d 21, d 22, and d 35 of age. These results for IL-12 
suggest that the probiotic treatment potentially had a positive effect on responsiveness to 
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processing (d 1A and d 1B of age) and weaning stress (d 21 of age) for PRO-piglets. These 
results were similar to the results that were found for the PRO-sows as well. The results found 
for PRO-piglets supports the above research by Deng at al., since the dietary supplementation of 
Scb may have affected the greater response to IL-12 reported. A review on parasites, probiotics, 
and piglets suggests that the underlying immunological mechanisms that ameliorate pathology 
showed no differences of T cells with a regulatory phenotype in probiotic-treated animals, as was 
previously described by Devaney (2014). However, results of the study on PRO-piglets found 
different results. On d 7 and d 21 of age during the suckling period, PRO-piglets had greater LPS 
measures than did CON-piglets. LPS (which function by eliciting strong immune responses in 
animals, thereby stabilizing the overall membrane structure (Black, 2011) results suggest that the 
probiotic treatment may have positively affected the PRO-piglets in response to short-term 
weaning stress (d 21 of age).  
 
Conclusion 
During the piglet study, it was hypothesized that sows fed the supplemented yeast 
probiotic diet, Scb, during the periods of late gestation until weaning could potentially transfer 
beneficial immune and stress responsiveness to her offspring. The maternal-fetal interaction that 
occurred in utero would likely be due to the Scb-supplemented diet fed to the PRO-sows during 
gestation, resulting in immune status and stress responsiveness effects on the offspring within 
24-hours post-birth. Overall, PRO-piglets were found to have greater innate and adaptive 
immune status than did CON-piglets during periods of farrowing and processing stress. At birth 
(d 0 of age). PRO-piglets had lower plasma cortisol and greater leukocyte differential 
(percentage of segmented neutrophils) in response to farrowing stress; while CON-piglets had 
greater total WBC count, leukocyte differential (percentage of lymphocytes), and cytokine IL-12 
at farrowing. In response to processing stress (d 1A and d 1B of age) PRO-piglets had greater 
total WBC count, leukocyte differential (percentage of segmented neutrophils), and cytokine IL-
12; while CON-piglets had lower plasma cortisol, as well as greater leukocyte differential 
(percentage of lymphocytes).  
During the weaning period, it was further hypothesized that piglets from PRO-sows 
would have a greater responsiveness to both the short- and long-term effects of acute stress 
compared to the CON-piglets. At d 21 of age (weaning), PRO-piglets had greater total WBC 
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count, neutrophil phagocytosis, cytokine IL-12, and LPS-induced mitogen proliferation index in 
response to acute farrowing stress; while CON-piglets had lower plasma cortisol and greater total 
lymphocyte count at weaning. Both CON and PRO piglets had similar responses to weaning (d 
21 of age) in regards to the leukocyte differential (percentage of segmented neutrophils and 
lymphocytes) and natural killer cell cytotoxicity. However, results varied between the CON and 
PRO piglets in regards to the measures that were assessed. The fewest effects on stress 
responsiveness or immunity were seen during the post-weaning period (i.e., long-term). This 
suggests that the probiotic treatment that the piglets had first experienced in utero may have 
diminished over time in the bodies of the PRO-piglets, leading to less of an impact during the 
weaning period. It is possible that feeding PRO-sows the yeast probiotic supplementation during 
the periods of gestation and lactation, resulted in positive outcomes of both innate and adaptive 
immune responses, leading to a maternal-fetal interaction, thereby transferring the immune status 




























(n = 42) 
Probiotic 
(n = 42) P-Value  
Plasma cortisol, ng/mL 
  
0.001* 
d0 204.54 ± 10.8
a
 111.17 ± 11.7
b
 
 d1A 30.8 ± 3.28 38.8 ± 5.52 
 d1B 50.5 ± 5.42
a
 64.2 ± 7.50
b
 
 d7 44.9 ± 12.1
a
 38.3 ± 3.43
b
 
 d14 38.6 ± 3.76 46.3 ± 7.14 
 d21 44.7 ± 3.48 50.5 ± 3.14 





d0 1.67 ± 0.17
a
 0.99 ± 0.18
b
 
 d1A 2.40 ± 0.23 2.65 ± 0.22 
 d1B 2.29 ± 0.21 2.42 ± 0.16 
 d7 5.93 ± 0.72 5.86 ± 0.52 
 d14 3.13 ± 0.35 3.10 ± 0.30 






d7 4.16 ± 0.38
a
 3.72 ± 0.14
b
 
 d14 2.22 ± 0.25 2.57 ± 0.35 






d7 2.70 ± 0.32
a
 4.19 ± 0.97
b
 
 d14 2.45 ± 0.55 4.01 ± 1.34 
 d21 8.02 ± 2.02
a
 3.85 ± 1.10
b
 
 Eosinophils, % 
  
0.85 
d0 0.43 ± 0.08 0.29 ± 0.07 
 d1A 0.48 ± 0.12 0.74 ± 0.15 
 d1B 0.12 ± 0.06 0.48 ± 0.11 
 d7 0.33 ± 0.11 0.52 ± 0.19 
 d14 0.45 ± 0.12 0.52 ± 0.11 
 d21 0.40 ± 0.13 0.36 ± 0.06 
 Banded Neutrophils, % 
  
0.35 
d0 1.17 ± 0.20 1.21 ± 0.02 
 d1A 1.29 ± 0.24 2.17 ± 0.36 
 d1B 0.98 ± 0.21
a
 2.90 ± 0.60
b
 
 d7 0.86 ± 0.19 1.02 ± 0.21 




Table 3.1 (Continued) 
d21 0.14 ± 0.06 0.41 ± 0.13 
 Segmented Neutrophils, % 
  
0.001* 
d0 51.0 ± 1.09
a
 58.0 ± 2.03
b
 
 d1A 67.0 ± 1.43 67.8 ± 1.63 
 d1B 58.5 ± 2.82
a
 64.9 ± 2.15
b
 
 d7 54.3 ± 2.34
a
 43.5 ± 2.13
b
 
 d14 37.1 ± 1.81
a
 32.3 ± 2.05
b
 
 d21 32.4 ± 1.86 32.0 ± 2.17 
 Lymphocytes, % 
  
0.001* 
d0 46.5 ± 1.06
a
 39.0 ± 2.04
b
 
 d1A 29.5 ± 1.64
a
 25.7 ± 1.62
b
 
 d1B 38.5 ± 2.73
a
 30.0 ± 2.51
b
 
 d7 42.5 ± 2.44
a
 52.8 ± 2.19
b
 
 d14 60.4 ± 1.91 64.6 ± 2.36 
 d21 66.1 ± 1.71 65.1 ± 2.14 
 Monocytes, % 
  
0.86 
d0 0.95 ± 0.16 1.57 ± 0.19 
 d1A 1.64 ± 0.28 2.64 ± 0.41 
 d1B 1.57 ± 0.32 1.71 ± 0.25 
 d7 2.33 ± 0.37 2.21 ± 0.34 
 d14 1.81 ± 0.28 1.24 ± 0.33 
 d21 1.60 ± 0.29 2.14 ± 0.32 
  
* 
Treatment x Day effect across suckling phase.
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
















(n = 42) 
Probiotic 




d7 67.6 ± 2.29 67.5 ± 2.58 
 d14 63.5 ± 1.75 60.3 ± 2.00 
 d21 56.2 ± 1.40 62.5 ± 1.65 
 Natural killer cells (NK) 12.5, % 
  
0.03*
d7 64.8 ± 7.11 67.9 ± 6.91 
 d14 98.12 ± 11.6 95.01 ± 12.7 
 d21 89.9 ± 11.3 88.7 ± 10.3 
 Interleukin-12 (IL-12 Elisa), pg/mL 
  
0.001*
d0 172.42 ± 7.42 162.79 ± 7.64 
 d1A 194.50 ± 11.2 212.65 ± 10.2 
 d1B 182.11 ± 12.7 202.57 ± 14.1 
 d7 167.33 ± 8.20 160.69 ± 7.10 
 d14 259.74 ± 16.5 276.68 ± 13.5 
 d21 298.00 ± 16.7 317.23 ± 16.6 
 Concanavalin A Proliferation (ConA), 20.0 
  
0.87
d7 2.29 ± 0.33 1.96 ± 0.28 
 d14 1.92 ± 0.17 1.74 ± 0.20 
 d21 2.53 ± 0.22 1.76 ± 0.18 




d7 1.48 ± 0.02
a
 1.75 ± 0.22
b
 
 d14 1.31 ± 0.09 1.14 ± 0.05 
 d21 1.46 ± 0.11
a






Treatment x Day effect across suckling phase.
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 















(n = 42) 
Probiotic 
(n = 42) P-Value  
Plasma cortisol, ng/mL 
  
0.026* 
d21 44.7 ± 3.48 50.5 ± 3.14 
 d22 37.0 ± 2.94
a
 53.0 ± 5.70
b
 
 d28 25.2 ± 1.69
a
 30.8 ± 2.38
b
  
d35 26.4 ± 1.93 24.5 ± 1.54  





d21 1.71 ± 0.11 2.13 ± 0.28 
 d22 1.99 ± 0.22
a
 1.27 ± 0.07
b
 
 d28 2.10 ± 0.19 1.99 ± 0.17 






d21 1.88 ± 0.20 1.94 ± 0.15 
 d22 1.68 ± 1.23
a
 1.64 ± 0.24
b
 
 d28 2.18 ± 0.21 2.03 ± 0.19  
d35 6.15 ± 0.44
a








d21 8.02 ± 2.02
a
 3.85 ± 0.30
b
 
 d22 2.53 ± 0.35
a
 1.39 ± 0.15
b
 
 d28 2.31 ± 0.23 2.33 ± 0.15  




d21 0.40 ± 0.13 0.36 ± 0.06 
 d22 0.38 ± 0.11 0.36 ± 0.11 
 d28 0.52 ± 0.15 1.19 ± 0.23 
 d35 1.10 ± 0.17 0.91 ± 0.13 
 Banded Neutrophils, % 
  
0.76 
d21 0.14 ± 0.06 0.41 ± 0.13 
 d22 0.48 ± 0.16 0.45 ± 0.14 
 d28 0.33 ± 0.11 0.52 ± 0.13  
d35 0.21 ± 0.06 0.48 ± 0.11  
Segmented Neutrophils, % 
  
0.019* 
d21 32.4 ± 1.86 32.0 ± 2.17 
 d22 40.2 ± 1.85 39.6 ± 2.54 
 d28 36.3 ± 2.04 34.0 ± 2.01  








Table 3.3 (Continued) 
d22 56.5 ± 1.98 57.2 ± 2.13 
 d28 59.4 ± 2.00 60.8 ± 1.95  




d21 1.60 ± 0.29 2.14 ± 0.32 
 d22 2.38 ± 0.36 2.31 ± 0.38 
 d28 2.90 ± 0.40 3.57 ± 0.50  
d35 1.62 ± 0.23 1.90 ± 0.22  
 
* 
Treatment x Day effect across weaning phase.
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-

























(n = 42) 
Probiotic 




d21 56.2 ± 2.40 62.5 ± 1.65 
 d22 70.1 ± 2.01
a
 65.5 ± 2.03
b
 
 d28 60.7 ± 1.33 62.4 ± 1.16  
d35 66.4 ± 1.15 68.5 ± 1.13  
Natural killer cells (NK) 12.5, % 
  
0.014* 
d21 89.9 ± 11.3 88.7 ± 10.3 
 d22 48.2 ± 8.53 45.1 ± 6.27 
 d28 87.5 ± 5.53
a
 73.7 ± 4.37
b
  
d35 52.8 ± 3.84
a
 44.8 ± 3.07
b
  
Interleukin-12 (IL-12 Elisa), pg/mL 
  
0.001* 
d21 298.00 ± 16.7 317.23 ± 16.6 
 d22 237.73 ± 10.2 243.13 ± 15.1 
 d28 426.98 ± 30.2 417.63 ± 21.5  
d35 320.67 ± 10.8
a
 349.73 ± 24.8
b
  
Concanavalin A Proliferation (ConA), 20.0 
  
0.54 
d21 2.53 ± 0.22 1.76 ± 0.18 
 d22 1.81 ± 0.28 2.32 ± 0.30 
 d28 2.42 ± 0.20 2.38 ± 0.23  
d35 2.24 ± 0.27 1.98 ± 0.20  
Lipopolysaccharide Proliferation (LPS), 20.0 
  
0.78 
d21 1.46 ± 0.09
a
 1.72 ± 0.27
b
 
 d22 1.66 ± 0.19 1.45 ± 0.19 
 d28 1.10 ± 0.10 1.49 ± 0.21  
d35 1.65 ± 0.17 1.80 ± 0.24  
 
* 
Treatment x Day effect across weaning phase.
 
a,b 
Within a row, means without a common superscript differ (P ≤ 0.05) 
c,d 
Within a row, means without a common superscript differ (trend at p > 0.05 and p ≤ 0.10) 
1 
Least squares means ± SE 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-









Figure 3.1 Treatment x day effect
1










 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.001
 
2 
Plasma cortisol, ng/mL 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
(post-processing), d 7, d 14, and d 21 (at weaning) of age. 













































Day of Lactation 






Figure 3.2 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.03
 
2 




Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
(post-processing), d 7, d 14, and d 21 (at weaning) of age. 



















































Day of Age 
Treatment x day effect1 on total white blood cell count2 of piglets3 





Figure 3.3 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.04
 
2 




Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 7, d 14, and d 21 (at weaning) of age. 













































Day of Age 
Treatment x day effect1 on total neutrophil count2 of piglets3 





Figure 3.4 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.001
 
2 




Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 7, d 14, and d 21 (at weaning) of age. 






































Day of Age 
Treatment x day effect1 on total lymphocyte count2 of piglets3 





Figure 3.5 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.001
 
2 
Leukocyte Differential-Segmented Neutrophils, % 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
(post-processing), d 7, d 14, and d 21 (at weaning) of age. 











































Day of Age 
Treatment x day effect1 on leukocyte differential2 of piglets3 





Figure 3.6 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.001
 
2 
Leukocyte Differential-Lymphocytes, % 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
(post-processing), d 7, d 14, and d 21 (at weaning) of age. 






































Day of Age 
Treatment x day effect1 on leukocyte differential2 of piglets3 





Figure 3.7 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.011
 
2 
Neutrophil phagocytosis, % 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 7, d 14, and d 21 (at weaning) of age. 










































Day of Age 
Treatment x day effect1 on neutrophil phagocytosis2 of piglets3 





Figure 3.8 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.03
 
2 
Cytotoxicity %, 12.5:1 effector to target 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 7, d 14, and d 21 (at weaning) of age. 









































Day of Age 
Treatment x day effect1 on natural killer cell cytotoxicity2 of piglets3 





Figure 3.9 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.001
 
2 
Interleukin-12 (IL-12), pg/mL 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 0 (day of birth), d 1A (pre-processing), d 1B 
(post-processing), d 7, d 14, and d 21 (at weaning) of age. 













































Day of Age 
Treatment x day effect1 on cytokine Interleukin-122 of piglets3 during 





Figure 3.10 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across suckling phase; p = 0.05
 
2 
Mitogen-induced proliferation, Lipopolysaccharide Proliferation (20 LPS), 20.0 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of suckling are equivalent to days of age: d 7, d 14, and d 21 (at weaning) of age. 
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Treatment x day effect1 on mitogen-induced proliferation 





Figure 3.11 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.026
 
2 
Plasma cortisol, ng/mL 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 
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Figure 3.12 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.03
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Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 










































Day of Age 
Treatment x day effect1 on total neutrophil count2 of piglets3 





Figure 3.13 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.02
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Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 











































Day of Age 
Treatment x day effect1 on total lymphocyte count2 of piglets3 





Figure 3.14 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.019
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Leukocyte Differential-Segmented Neutrophils, % 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 






































Day of Age 
Treatment x day effect1 on leukocyte differential2 of piglets3 





Figure 3.15 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.04
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Leukocyte Differential-Lymphocytes, % 
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Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 





































Day of Age 
Treatment x day effect1 on leukocyte differential2 of piglets3 





Figure 3.16 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.012
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Neutrophil phagocytosis, % 
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Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 
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Treatment x day effect1 on neutrophil phagocytosis2 of 





Figure 3.17 Treatment x day effect
1











 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.014
 
2 
Cytotoxicity %, 12.5:1 effector to target 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 










































Day of Age 
Treatment x day effect1 on natural killer cell cytotoxicity2 of piglets3 





Figure 3.18 Treatment x day effect
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 Least squares means ± SE; Treatment x day effect across weaning phase; p = 0.001
 
2 
Interleukin-12 (IL-12), pg/mL 
3 
Control (CON) vs. Probiotic (PRO) piglets 
4 
Days of post-weaning are equivalent to days of age: d 21 (at weaning), d 22 (24-hours post-
weaning), d 28 (7 days post-weaning), and d 35 (14 days post-weaning) of age. 
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Treatment x day effect1 on cytokine Interleukin-122 of piglets3 during 
















Least squares means ± SE  
2 
Control vs. Probiotic piglets 
3 
Body Weight, kg 
4 
Days of suckling and weaning are equivalent to days of age: d 1B (post-processing), d 7, d 14, d 
21 (at weaning), d 22 (24-hours post-weaning), d 28 (7 days post-weaning), and d 35 (14 days 
post-weaning) of age. 
Piglet body weight (kg), for CON and PRO piglets was recorded during the suckling and 
weaning periods. During suckling, days 1B (post-process), 7, 14, and 21 (at weaning) of age 
were reported. During the weaning period, days 21 (at weaning), 22, 28, and 35 of age were 
reported. Throughout the study, piglet body weight was similar between the CON and PRO 
piglets. Therefore, for each time point taken, piglet body weight was similar, regardless of 
whether they were offspring from dams fed the control (CON) or probiotic (PRO) treatments 
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The transfer of glucocorticoids from mother to fetus plays an important role in fetal 
programing of the HPA axis of offspring, as it has a direct effect on the brain (Nuriel-Ohayon, 
2016; Wu et al., 1998). Direct maternal-fetal effects occur via the HPA axis, limbic system, and 
hippocampus, while indirect effects occur in the fetal organ system. In addition, glucocorticoids 
are important for normal development of the fetus, via growth and maturation of organ systems. 
The surge in glucocorticoids results in a developmental switch that results in changes in gene 
regulation in the organs/brain of the offspring, and these changes affect postnatal life. Maternal 
stress exposures to glucocorticoids results in long-term programming of HPA function and 
behaviors. This is because synthetic glucocorticoids can cross the placenta and enter the fetal 
brain, which in turn downregulates and has an effect on brain development (Nuriel-Ohayon, 
2016; Wu et al., 1998). When presented with a challenge, such as farrowing and weaning 
stressors in sows or farrowing, processing, and weaning stressors in piglets, the yeast probiotic, 
Saccharomyces cerevisiae boulardii (Scb) was shown to have varying results for treatment x day 
interactions on both stress responsiveness and immune status of pigs. These data imply that the 
increased immune status and decreased stress response of the sows and piglets are interrelated in 
some cases, which may be altered by feeding Scb to sows during gestation and lactation.  
In general, in the sow study, there were fewer treatment x day interactions than were 
reported for the effects that maternal treatment had on the piglets. This may suggest that the 
probiotic treatment of the sow affects the physiological responses of her offspring at farrowing 
and post-weaning. Results of the sow study, indicated that yeast probiotics fed from d 84 to d 
112 of gestation and through lactation in response to stressors may be differentially affected by 
the immune and cortisol profile of the gestating sow. In general, plasma cortisol, innate immune 
measures (NK and chemotaxis), IL-12, and leukocyte subpopulations differed, with most 
immune measures being stimulated and cortisol being reduced. Moreover, feeding probiotics to 
sows during both gestation and lactation had an effect on her offspring. The piglets’ profile 
found that total WBC count, total neutrophil and lymphocyte counts, innate immune measures 
(NK and phagocytosis), adaptive immune measures (LPS), IL-12, and leukocyte subpopulations 
differed, with most immune and adaptive measures being stimulated and cortisol being reduced. 
Feeding Scb to sows was hypothesized to have an overall improved innate and adaptive 
immune status and cortisol levels, which would result in a greater responsiveness to acute 
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farrowing and weaning stress when compared to the CON-sows. Overall, PRO-sows were found 
to have greater innate immune responses, as well as lower plasma cortisol concentrations than 
did CON-sows. At d 31 (24-hours post-farrowing) post-treatment, PRO-sows had greater 
cytokine IL-12, and leukocyte differential (percentage of eosinophils, banded neutrophils, and 
lymphocytes), as well as lower plasma cortisol, in response to farrowing stress. However, CON-
sows had greater natural killer cell cytotoxicity, neutrophil chemotaxis C5a, and leukocyte 
differential (percentage of segmented neutrophils and monocytes) at 24-hours post-farrowing. At 
d 51 (at weaning) post-treatment, PRO-sows had greater natural killer cell cytotoxicity, cytokine 
IL-12, and leukocyte differential (percentage of eosinophils, banded neutrophils, and 
lymphocytes), as well as lower plasma cortisol, in response to weaning stress. CON-sows, on the 
other hand, only had greater leukocyte differential (percentage of segmented neutrophils and 
monocytes) at weaning. These results showed that while CON and PRO sows both elicited 
differing immune responses to these stressors, the PRO-sows did have an overall greater 
response, especially in terms of a lower plasma cortisol concentration and a greater subset of the 
leukocyte differential and cytokine IL-12 at both lactation treatment days.  
Previous research has indicated that plasma cortisol secretion in sows increases at the 
time of farrowing and weaning (Anil et al., 2005; Tsuma et al., 1995). However, results in this 
study showed both PRO-sows and piglets having lower plasma cortisol at farrowing than did 
CON-sows and piglets. This part of the cortisol response could be reflective of the sows’ 
maternal-fetal influence, which occurred when the PRO-sows were fed Scb during the gestation 
period. In addition, PRO-sows had lower plasma cortisol at weaning than did CON-sows. 
However, CON-piglets had lower plasma cortisol concentration at weaning than did PRO-
piglets. The PRO-sows greater responsiveness to farrowing and weaning stressors did not show 
any detrimental effects, as body weight remained unaffected by these changes, which is also true 
for the piglets at farrowing.  
In the piglet study, it was hypothesized that sows fed the supplemented yeast probiotic 
diet, Scb, during the periods of late gestation until weaning could potentially transfer beneficial 
immune and stress responsiveness to her offspring. Therefore, piglets born to the probiotic-
treated sows (PRO-piglets) were hypothesized as having an enhanced responsiveness to 
farrowing and processing stressors when compared to the piglets born to the control sows (CON-
piglets). The maternal-fetal interaction that occurred in utero would likely be due to the Scb-
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supplemented diet fed to the PRO-sows during gestation, resulting in immune status and stress 
responsiveness effects on the offspring within 24-hours post-birth. Overall, PRO-piglets were 
found to have greater innate and adaptive immune status than did CON-piglets during periods of 
farrowing and processing stress. At d 0 of age (birth), PRO-piglets had lower plasma cortisol and 
greater leukocyte differential (percentage of segmented neutrophils) in response to farrowing 
stress. However, CON-piglets had greater total WBC count, leukocyte differential (percentage of 
lymphocytes), and cytokine IL-12 at farrowing. At d 1A and d 1B (pre- and post-process) of age, 
PRO-piglets had greater total WBC count, leukocyte differential (percentage of segmented 
neutrophils), and cytokine IL-12 in response to processing stressors. CON-piglets, on the other 
hand, had lower plasma cortisol, as well as greater leukocyte differential (percentage of 
lymphocytes) before and after processing. These results showed that while CON and PRO piglets 
both elicited differing immune responses to these stressors, the PRO-piglets did have an overall 
greater response at farrowing (d 0 of age), especially in terms of a lower plasma cortisol 
concentration and a greater subset of the neutrophil leukocyte differential. However, during 
processing (d 1A and d 1B of age), both CON and PRO piglets had a similar response.   
The first weeks of life constitute the most critical period for piglets, since they can be 
exposed to conditions that negatively influence neonatal immune responses, thereby 
compromising their ability to resist and combat pathogenic challenges. Factors such as 
environmental stressors, husbandry practices, and antigenic exposures of sows each may 
negatively affect the early development of the piglet’s immune system, with a probable increase 
in susceptibility to infection or disease and a reduction in growth and performance. Prenatal 
maternal stress during late-gestation can impair the development and reactivity of the immune 
system of a sow’s offspring and impacts the frequency of disease and mortality (Tuchscherer et 
al., 2002). During the weaning period, it was also hypothesized that piglets from PRO-sows will 
have a greater responsiveness to both the short- and long-term effects of acute stress compared to 
the CON-piglets. At d 21 (weaning) of age, PRO-piglets had greater total WBC count, neutrophil 
phagocytosis, cytokine IL-12, and LPS-induced mitogen proliferation index in response to acute 
farrowing stress. However, CON-piglets had lower plasma cortisol and greater total lymphocyte 
count at weaning. Both CON and PRO piglets had similar responses to weaning (d 21 of age) in 
regards to the leukocyte differential (percentage of segmented neutrophils and lymphocytes) and 
natural killer cell cytotoxicity. The fewest effects on stress responsiveness or immunity were 
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seen during the post-weaning period (i.e., long-term). This suggests that the probiotic treatment 
that the piglets had first experienced in utero may have diminished over time in the bodies of the 
PRO-piglets, leading to less of an impact during the weaning period.  
There are numerous benefits to the research that was conducted within this thesis. The 
sustainability of the swine industry, which includes the health and welfare of the swine 
themselves, includes optimizing the parameters of animal well-being (e.g., behavioral, 
physiological, immunological, and performance measures). Probiotics will expectantly lessen the 
impact of animal-health issues and other unavoidable stressors that often challenge food animals. 
Moreover, this feed additive may reduce the incidence of infectious disease outbreaks, thereby 
optimizing health so that the need for sub-therapeutic antibiotics declines (Cheng et al., 2014; 
Cho et al., 2011). Probiotics can therefore be used as an alternative feed supplement to 
combating the negative impacts of antibiotics on the gut microbiota and overall health of the 
animal. New methods of promoting feed efficiency and health are especially important in 
situations where farm animal populations are more susceptible to new challenges. These methods 
can also be aimed at implementing new alternatives to weaning, so that separation of the dam 
and her piglets may be carried out in a manner that utilizes low stress level methods. Therefore, 
the goal of utilizing probiotics as an alternative feed additive to antibiotics in swine production 
includes the long term sustainability of animal husbandry.  
Because of inconsistency in results, it is possible that altering the experimental design of 
this study could result in greater stress responsiveness and immune effects in the probiotic-
treated animals. This may include increasing the dosage of the probiotic given to the sows, using 
a different strain of probiotic as the main supplemented feed additive, or measuring additional 
innate and adaptive immune metrics in order to further analyze the effects of the probiotic. Even 
though effects were not consistent, based on the general lack of changes in the CON-sows, some 
aspects of innate immunity implied the PRO-sows’ immune system was being affected by the 
Scb probiotic. Future research should focus on increasing the overall understanding of combining 
the use of antibiotics and probiotics as feed additives that would maintain a healthy agricultural 
economy, while also promoting human health. The positive effects that probiotics extend to 
animals have also been noted to be more effective and consistent when administered to weaned 
piglets versus growing finishing pigs (Falaye et al., 2016). Upon weaning, the intestinal 
microflora of piglets is altered due to dietary and environmental changes, allowing for probiotics 
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to have a greater and more influential role at this time. Therefore, future research may also 
consider directly feeding probiotics to piglets, particularly around the time of weaning to 
potentially reduce the negative impact of stressors.  
It is possible that feeding PRO-sows the yeast probiotic supplementation during the 
periods of gestation and lactation, resulted in positive outcomes of both innate and adaptive 
immune responses. This was specifically seen in the treatment x day interactions noted 
previously; however, results varied between the control and probiotic-treated animals. These 
interactive effects may have also aided the PRO-sows in having a decreased stress response to 
farrowing and weaning stressors. This was seen in the cases where innate and adaptive immune 
measures were greater in PRO-sows when compared to CON-sows, in addition to PRO-sows 
having lower plasma cortisol during the lactation period (thereby decreasing responsiveness to 
farrowing and weaning stress). Feeding modified gestation diets to sows throughout pregnancy 
may reduce the incidence of infectious disease outbreaks, thereby optimizing health so that the 
need for sub-therapeutic antibiotics declines. Therefore, the supplementation of the yeast 
probiotic boluses, Scb, during the period of gestation to weaning did have an impact on the 
immune status and stress response of PRO-sows during gestation and lactation. Maternal diet, 
during pregnancy and throughout lactation, affects the microbiota by potentially changing the 
abundance and type of bacteria that can be transferred from mother to offspring during the 
periods of gestation, and even in the early life of offspring (Nuriel-Ohayon, 2016). A potential 
mechanism of great importance to this topic is the microbial transmission across the maternal-
fetal interface within the placenta. Feeding Scb to PRO-sows during gestation and lactation may 
have had a maternal-fetal interaction, thereby transferring the immune status and stress 
responsiveness effects from the dam to her offspring. The use of probiotic-supplemented feeds 
may lessen the impact of animal-health issues and other unavoidable stressors that often 
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